C. Angelini

C. Angelini, E. Buratti, F. Baralle, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

TARDBP (TDP‐43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations

N. Bresolin, S. Corti, M. Mancuso, 2009, European journal of neurology.

Acute Quadriplegic Myopathy in a 17-Month-Old Boy

C. Angelini, L. Salviati, L. Zancan, 2000, Journal of child neurology.

Intensive Care Unit-Acquired Weakness

C. Angelini, M. Meznaric, 2016 .

Measurement of the beauty production cross section in 350 GeV / c π-Cu interactions

P. Mazzanti, A. Semenov, P. Musico, 1998 .

Measurements of charmed-meson production in interactions between 350 GeV/c π− particles and nuclei

P. Mazzanti, D. Barberis, F. Ceradini, 1997 .

Search for the flavour-changing neutral-current decay D0 → μ+μ−

P. Mazzanti, D. Barberis, F. Ceradini, 1997 .

Determination of the neutral current chiral coupling constants uL2, uR2, dL2 and dR2 from a neutrino and antineutrino deuterium experiment

A. G. Frodesen, N. Eijndhoven, J. Derkaoui, 1988 .

Search for the charmed pentaquark candidate Θc(3100)0 in e+e- annihilations at s=10.58GeV

Fry, Azzolini, Wagner, 2006, hep-ex/0604006.

B meson decays to η(′) K*, η (′) ρ, η(′) π0, ωπ0, and φπ0

G. B. Mohanty, Y. S. Zhu, G. J. Grenier, 2004 .

Measurement of an excess of [¯ over B] → D[superscript (*)]τ[superscript -]ν[¯ over v][subscript τ] decays and implications for charged Higgs bosons

D. Leith, R. Field, K. Honscheid, 2013 .

Measurement of an excess of B̄→D(*) τ-ν̄τ decays and implications for charged Higgs bosons

D. Leith, R. Field, K. Honscheid, 2013, 1303.0571.

Title Measurement of an excess of B̄ → D ( * ) τ-ν̄τ decays and implications for charged Higgs bosons Permalink

D. Leith, R. Field, K. Honscheid, 2013 .

Observation of tree-level B decays with ss production from gluon radiation.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Evidence for an Excess of B !

J. R. Wilson, D. Leith, R. Field, 2012 .

Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases

C. Angelini, G. Merla, M. Filocamo, 2013, Orphanet Journal of Rare Diseases.

Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy

E. Bertini, A. D’Amico, C. Angelini, 2012, European Journal of Human Genetics.

Measurement of CP-violating asymmetries in B0-->D*(+/-)D(-/+).

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Direct CP violating asymmetry in B0-->K+pi- decays.

G. J. Grenier, R. Field, S. Bailey, 2004, Physical review letters.

Search for CP violation in the decays D0 --> K- K+ and D0 --> pi- pi+.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Search for T and CP violation in B-0-(B)over-bar(0) mixing with inclusive dilepton events

D. Leith, S. Schaffner, M. Kunze, 2002 .

Measurement of Z(0) and Drell-Yan production cross sections using dimuons in (p)over-bar-p collisions at root s=1.8TeV

Amendolia, Shapiro, D. Leith, 1999 .

Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin‐responsive, multiple acyl‐CoA dehydrogenase deficiency patient

A. Tramontano, C. Angelini, E. Pegoraro, 2006, Electrophoresis.

Burden, professional support, and social network in families of children and young adults with muscular dystrophies

L. Magliano, M. Pane, A. D’Amico, 2015, Muscle & nerve.

Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study

L. Magliano, M. Pane, A. D’Amico, 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Silicon Vertex Tracker : Status and Prospects

M. Datta, D. Kirkby, N. Roe, 2006 .

Lessons learned from BaBar silicon vertex tracker, limits and future perspectives of the detector

M. Datta, D. Kirkby, N. Roe, 2004, IEEE Symposium Conference Record Nuclear Science 2004..

Performance, radiation damage, and future plans of the BABAR silicon vertex tracker

M. Datta, D. Kirkby, N. Roe, 2004, IEEE Transactions on Nuclear Science.

The BaBar silicon vertex tracker, performance and running experience

J. Beringer, J. Nielsen, D. Kirkby, 2002 .

Measurement of the $B^{0}$ meson properties using partially reconstructed $B^{0} \to D^{*-}\pi^{+}$ and $B^{0} \to D^{*-}l^{+}\nu$ decay with the BABAR detector

D. Leith, S. Schaffner, M. Kunze, 2000 .

Search for a Dark Photon in e[superscript +]e[superscript −] Collisions at BABAR

D. Leith, R. Field, K. Honscheid, 2014 .

Inclusive J/ ? and ?' production in p --nucleus interactions at vs ? 26 GeV

P. Mazzanti, D. Barberis, F. Ceradini, 1999 .

7 Defects of fatty-acid oxidation in muscle

C. Angelini, 1990 .

Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases

G. Apolone, G. Meola, M. Rose, 2010, European journal of neurology.

The natural history of cardiac involvement in myotonic dystrophy: An eight‐year follow‐up in 17 patients

C. Angelini, M. Armani, R. Scognamiglio, 1988, Clinical cardiology.

Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy.

F. Crea, C. Angelini, G. Siciliano, 1989, Journal of the American College of Cardiology.

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy

G. Comi, E. Hoffman, C. Angelini, 2015, PloS one.

Evidence for D0-D0 mixing.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Evidence for b → d γ transitions from a sum of exclusive final states in the hadronic final state mass range 1.0GeV/c2 < M(X d) < 1.8GeV/c2

D. Leith, R. Field, K. Honscheid, 2007 .

Elevated Expression of Moesin in Muscular Dystrophies.

O. Halevy, C. Angelini, M. Pines, 2017, The American journal of pathology.

Decorin and biglycan expression is differentially altered in several muscular dystrophies.

C. Angelini, T. Negri, E. Pegoraro, 2005, Brain : a journal of neurology.

Limb girdle muscular dystrophies: clinical-genetical diagnostic update and prospects for therapy

C. Angelini, M. Fanin, 2017 .

MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B

C. Angelini, C. Rodolico, A. Toscano, 2016, Cell biochemistry and function.

EFNS guidelines on the diagnostic approach to pauci‐ or asymptomatic hyperCKemia

C. Angelini, G. Siciliano, S. Sacconi, 2010, European journal of neurology.

Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms.

C. Angelini, Corrado Angelini, 2004, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease.

C. Angelini, P. Tonin, M. Filosto, 2015, The Journal of clinical endocrinology and metabolism.

Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes

C. Angelini, E. Ricci, G. Piluso, 2005, Journal of Medical Genetics.

The extensive scanning of the calpain-3 gene broadens the spectrum of LGMD 2 A phenotypes

Enzo, C. Angelini, G. Piluso, 2004 .

Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients

E. Bertini, D. Tavian, S. Missaglia, 2017, Orphanet Journal of Rare Diseases.

Q2 dependence of the proton and neutron structure functions from neutrino and antineutrino scattering in deuterium

A. G. Frodesen, M. Loreti, N. Eijndhoven, 1985 .

Fragmentation functions in high energy ν and ν deuterium interactions

A. G. Frodesen, M. Loreti, P. Mazzanti, 1983 .

Direct CP, lepton flavor, and isospin asymmetries in the decays B-->K(*)l+l-.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Performance studies of the Belle II Silicon Vertex Detector with data taken at the DESY test beam in April 2016

M. M. Kolwalkar, K. Nakamura, M. Friedl, 2017 .

Muscle disorders

C. Angelini, G. Novelli, G. Bonanni, 2005, Journal of Neurology.

Enzyme Replacement Therapy Improves Respiratory Outcomes in Patients with Late-Onset Type II Glycogenosis and High Ventilator Dependency

C. Angelini, E. Pegoraro, S. Servidei, 2013, Lung.

MRI in neutral lipid storage disease (NLSD)

E. Bertini, A. D’Amico, C. Angelini, 2017 .

Muscle MRI in neutral lipid storage disease (NLSD)

E. Bertini, A. D’Amico, C. Angelini, 2017, Journal of Neurology.

The frequency of limb girdle muscular dystrophy 2A in northeastern Italy

C. Angelini, A. Nascimbeni, M. Fanin, 2005, Neuromuscular Disorders.

The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)

C. Angelini, A. Nascimbeni, M. Fanin, 2010, Neurological research.

Infantile lipid storage myopathy with nocturnal hypoventilation shows abnormal low-affinity muscle carnitine uptake in vitro

C. Angelini, L. Vergani, 1999, Neuromuscular Disorders.

Mitochondrial disorders of the nuclear genome.

C. Angelini, L. Bello, M. Spinazzi, 2009, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Muscle atrophy in Limb Girdle Muscular Dystrophy 2A: a morphometric and molecular study

C. Angelini, M. Fanin, A. Nascimbeni, 2013, Neuropathology and applied neurobiology.

Prevention of cardiomyopathy in Duchenne muscular dystrophy

C. Angelini, 2015, The Lancet Neurology.

Measurement of branching fractions and search for CP-violating charge asymmetries in charmless two-body B decays into pions and kaons.

S. Schaffner, M. Kunze, J. Beringer, 2001, Physical review letters.

Contents Vol. 8, 2011

Jane S. Paulsen, Robert P. Davis, J. L. Mesa, 2011, Neurodegenerative Diseases.

Myoclonus in mitochondrial disorders

M. Zeviani, M. Mancuso, C. Angelini, 2014, Movement disorders : official journal of the Movement Disorder Society.

Molecular and muscle pathology in a series of caveolinopathy patients

C. Angelini, G. Piluso, L. Politano, 2005, Human mutation.

Carnitine deficiency, organic acidemias, and Reye's syndrome

C. Angelini, W. Parker, D. Stumpf, 1985, Neurology.

Review: Danon disease: Review of natural history and recent advances

C. Angelini, G. Cenacchi, M. Fanin, 2019, Neuropathology and applied neurobiology.

Autophagy dysregulation in Danon disease

C. Angelini, M. Sandri, A. Nascimbeni, 2017, Cell Death & Disease.

The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)

C. Angelini, M. Sandri, E. Masiero, 2012, Cell Death and Differentiation.

- 181-Multisystemic LAMP-2 defect in Danon disease

C. Angelini, A. Nascimbeni, M. Fanin, 2008 .

Cardioembolic stroke in Danon disease

C. Angelini, M. Fanin, P. Melacini, 2008, Clinical genetics.

Multisystemic LAMP-2 defect in Danon disease.

C. Angelini, A. Nascimbeni, M. Fanin, 2007 .

Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.

C. Angelini, A. Nascimbeni, M. Fanin, 2006, The American journal of pathology.

Effects of short‐to‐long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)

G. Comi, C. Angelini, P. Tonin, 2018, Neuropathology and applied neurobiology.

Lipolysis and lipophagy in lipid storage myopathies

C. Angelini, A. Nascimbeni, G. Cenacchi, 2016, Biochimica et biophysica acta.

cDNA Sequencing of Nuclear NADH Dehydrogenase Subunit Genes in Complex I Deficient Myopathic Patients

A. Brookes, J. Prince, C. Angelini, 2000 .

Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients

C. Angelini, M. Sandri, E. Masiero, 2012, Autophagy.

Diagnostic challenges in metabolic myopathies

C. Angelini, S. Sacconi, V. Pegoraro, 2020, Expert review of neurotherapeutics.

Impaired autophagy affects acid α‐glucosidase processing and enzyme replacement therapy efficacy in late‐onset glycogen storage disease type II

C. Angelini, M. Sandri, A. Nascimbeni, 2015, Neuropathology and applied neurobiology.

Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure

C. Angelini, P. Navas, E. Trevisson, 2015, European Journal of Human Genetics.

Muscle atrophy, ubiquitin–proteasome, and autophagic pathways in dysferlinopathy

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Muscle & nerve.

Enzyme replacement therapy for the treatment of Pompe disease

C. Angelini, 2018 .

Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency

C. Angelini, A. Nascimbeni, M. Fanin, 2008, Neurology.

European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience

M. Roberts, C. Angelini, R. Lachmann, 2017, European journal of neurology.

Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years

C. Angelini, M. Ermani, G. Siciliano, 2012, Journal of Neurology.

New motor outcome function measures in evaluation of Late‐Onset Pompe disease before and after enzyme replacement therapy

G. Comi, C. Angelini, G. Siciliano, 2012, Muscle & nerve.

Next generation sequencing detection of late onset pompe disease

C. Angelini, V. Nigro, M. Fanin, 2016, Muscle & nerve.

Spectrum of metabolic myopathies.

C. Angelini, 2015, Biochimica et biophysica acta.

Autophagy in Natural History and After ERT in Glycogenosis Type II.

C. Angelini, A. Nascimbeni, M. Fanin, 2015, JIMD reports.

Therapeutic advances in the management of Pompe disease and other metabolic myopathies

C. Angelini, A. Nascimbeni, C. Semplicini, 2013, Therapeutic advances in neurological disorders.

Abstracts of the 2017 Spring PaduaMuscleDays , Padua , Italy

M. Krenn, C. Angelini, J. Jarvis, 2017 .

Role of Gabapentin in Spinal Muscular Atrophy

E. Bertini, C. Angelini, A. Solari, 2003, Journal of child neurology.

Motor function–muscle strength relationship in spinal muscular atrophy

E. Bertini, C. Angelini, C. Minetti, 2004, Muscle & nerve.

Can miR-34a be suitable for monitoring sensorineural hearing loss in patients with mitochondrial disease? A case series

L. Dipietro, C. Angelini, M. Ralli, 2020, The International journal of neuroscience.

A Late-Onset Case of Neutral Lipid Storage Disease with Myopathy, Dropped Head Syndrome, and Peripheral Nerve Involvement

S. Dimauro, D. Tavian, S. Missaglia, 2013 .

New therapies in muscular dystrophies

C. Angelini, D. Bonifati, 2000, Neurological Sciences.

Epidemiology of motor neuron disease in north-east Veneto region: Venice, Padua, and Belluno Provinces (1972-1981).

C. Angelini, M. Armani, R. Candeago, 1987, Advances in experimental medicine and biology.

Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls

C. Angelini, M. Fanin, 2015, Muscle & nerve.

LGMD2E patients risk developing dilated cardiomyopathy

C. Angelini, E. Pegoraro, M. Fanin, 2003, Neuromuscular Disorders.

Clinical and molecular study in congenital muscular dystrophy with partial laminin α2 (LAMA2) deficiency

R. Finkel, E. Hoffman, Z. Tezak, 2003, Human mutation.

A novel laminin α2 isoform in severe laminin α2 deficient congenital muscular dystrophy

E. Hoffman, C. Angelini, E. Pegoraro, 2000, Neurology.

Measurements of the branching fractions and bounds on the charge asymmetries of charmless three-body charged B decays.

D. Leith, B. Brau, R. Field, 2003, Physical review letters.

Measurement of the neutron and proton structure functions from neutrino and antineutrino scattering in deuterium

A. G. Frodesen, M. Loreti, J. Derkaoui, 1984 .

Search for b→u transitions in B-→DK- and D*K- decays

D. Leith, K. Honscheid, D. Kirkby, 2010 .

The Physics of the B Factories

J. J. Walsh, K. F. Chen, R. Kass, 2001, 1406.6311.

Progress on high-resolution tracking with scintillating fibres: a new detector based on capillaries filled with liquid scintillator

C. Roda, C. Angelini, C. Via, 1992 .

Decreased fatty acid beta-oxidation in riboflavin-responsive, multiple acylcoenzyme A dehydrogenase-deficient patients is associated with an increase in uncoupling protein-3.

A. Russell, C. Angelini, L. Vergani, 2003, The Journal of clinical endocrinology and metabolism.

Muscle Carnitine Deficiency in Patients With Severe Peripheral Vascular Disease

R. Carrozzo, C. Angelini, G. Brevetti, 1991, Circulation.

Measurement of the B--> J/psiK*(892) decay amplitudes.

S. Schaffner, M. Kunze, J. Beringer, 2001, Physical review letters.

Search for decays of B0-->e+ e-, B0-->mu+ mu-, B0-->e +/- mu-/+.

Y. S. Zhu, B. Brau, R. Field, 2005, Physical review letters.

Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma.

X. Chen, D. Leith, R. Field, 2009, Physical review letters.

Search for lepton flavor violation in the decay tau+/--->e+/-gamma.

R. Kass, K. Honscheid, D. Kirkby, 2005, Physical review letters.

Search for lepton-flavor violation in the decay tau- --> l- l+ l-.

D. Leith, B. Brau, R. Field, 2003, Physical review letters.

Neutral Lipid Storage Disease with Myopathy

C. Angelini, 2014 .

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.

A. Policicchio, M. Chiariello, C. Angelini, 1988, Circulation.

Prognostic factors in mild dystrophinopathies

G. Danieli, C. Angelini, G. Siciliano, 1996, Journal of the Neurological Sciences.

Measurement of ratios of branching fractions and CP-violating asymmetries of B±→D*K± decays

D. Leith, R. Field, K. Honscheid, 2008 .

Measurement of the Time-Dependent CP Asymmetry in B;{0}-->D_{CP};{(*)}h;{0} Decays.

R. Kass, D. Leith, R. Field, 2007, Physical review letters.

Laminin α2 muscular dystrophy

T. Crawford, E. Hoffman, R. Zimmerman, 1998, Neurology.

Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants

C. Angelini, A. Cagnin, F. Boaretto, 2014, Neurobiology of Aging.

Tubular aggregates: Sarcoplasmic reticulum origin, calcium storage ability, and functional implications

C. Angelini, R. Betto, S. Ringel, 1985, Muscle & nerve.

Familial neuromuscular disease with tubular aggregates

C. Angelini, M. Armani, L. Vergani, 1985, Muscle & nerve.

Distal hereditary motor neuropathy type 1

C. Angelini, 2020, Definitions.

Distal Spinal Muscular Atrophy

C. Angelini, 2014 .

DUCHENNE CARRIER DETECTION

G. Danieli, C. Angelini, M. Healy, 1976, The Lancet.

DUCHENNE CARRIER DETECTION

G. Danieli, C. Angelini, 1976, The Lancet.

Deflazacort in Duchenne dystrophy: Study of long‐term effect

C. Angelini, E. Pegoraro, A. Pini, 1994 .

Multiplicity distributions of charged hadrons produced in (anti)neutrino-deuterium charged- and neutral-current interactions

A. G. Frodesen, N. Eijndhoven, J. Derkaoui, 1989 .

Search for the decay $\tau^ - \to 3 \pi^ - 2 \pi^ + 2 \pi^0 \nu_ tau $

Fry, Azzolini, Wagner, 2005 .

Branching fractions and CP asymmetries in B0-->K+ K- K0 S and B+-->K+ K0 S K0 S.

B. Brau, R. Field, S. Bailey, 2004, Physical review letters.

Searches for B0 decays to combinations of two charmless isoscalar mesons.

B. Brau, R. Field, S. Bailey, 2004, Physical review letters.

Measurement of Time-Dependent CP Asymmetry in B0->D^(*)+-pi-+ Decays and Constraints on |sin(2beta+gamma)|

R. Kass, B. Brau, R. Field, 2003, hep-ex/0308018.

Evidence for the rare decay B-->K*l+l- and measurement of the B-->Kl+l- branching fraction.

J. Beringer, B. Brau, R. Field, 2003, Physical review letters.

Measurement of the semileptonic branching fractions of the D0 meson

D. Leith, R. Field, K. Honscheid, 1996, 1110.5600.

Psychiatric disturbances associated with myasthenia gravis

C. Angelini, H. Merskey, G. Magni, 1988, Acta psychiatrica Scandinavica.

Measurement of branching fractions and rate asymmetries in the rare decays B -> K((*))l(+)l(-)

D. Leith, R. Field, K. Honscheid, 2012 .

Search for hadronic decays of a light Higgs boson in the radiative decay Υ→γA0.

D. Leith, R. Field, K. Honscheid, 2011, Physical review letters.

A novel out-of-frame mutation in the neurofilament light chain gene ( NEFL) does not result in Charcot-Marie-Tooth disease type 2E

C. Angelini, G. Siciliano, E. Pegoraro, 2005, Neurogenetics.

Radiological evidence of subclinical dysphagia in motor neuron disease

C. Angelini, M. Ermani, C. Briani, 1998, Journal of Neurology.

ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion

C. Angelini, M. Ermani, E. Pegoraro, 2011, Neurology.

A pilot trial with clenbuterol in amyotrophic lateral sclerosis

C. Angelini, E. Pegoraro, L. Vergani, 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Myotonic Dystrophy Type 1, Steinert Disease

C. Angelini, 2014 .

Retrospective study on PET–SPECT imaging in a large cohort of myotonic dystrophy type 1 patients

C. Angelini, M. Ermani, E. Pegoraro, 2010, Neurological Sciences.

Intellectual Impairment and Cognitive Evoked Potentials in Myotonic Dystrophy

C. Angelini, M. Ermani, M. Armani, 1989, The Journal of nervous and mental disease.

Limb-Girdle Muscular Dystrophy Type 1A

C. Angelini, 2018 .

Genetic Neuromuscular Disorders

C. Angelini, 2018, Springer International Publishing.

Progress in enzyme replacement therapy in glycogen storage disease type II

C. Angelini, P. Tonin, E. Pegoraro, 2009, Therapeutic advances in neurological disorders.

Erratum: Search for di-muon decays of a low-mass Higgs boson in radiative decays of the Υ(1S) (Physical Review D (2013) 87 (031102R))

D. Leith, R. Field, K. Honscheid, 2013 .

Search for production of invisible final states in single-photon decays of Υ(1S).

X. Chen, D. Leith, R. Field, 2010, Physical review letters.

www.cognizantcommunication.com Gene Expression Analysis in Myotonic Dystrophy: Indications for a Common Molecular Pathogenic Pathway in DM1 and

G. Meola, C. Angelini, G. Novelli, 2022 .

Rippling muscle disease and facioscapulohumeral dystrophy-like phenotype in a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion: Further evidence for “double trouble” overlapping syndromes

G. Alí, C. Angelini, G. Siciliano, 2012, Neuromuscular Disorders.

Myasthenia Gravis with Anti-MuSK Antibodies: Clinical Features and Histopathological Changes

C. Angelini, E. Albertini, S. Martignago, 2012 .

Correlating phenotype and genotype in the periodic paralyses

Timothy A. Miller, R. Griggs, J. Mendell, 2004, Neurology.

Myotonic Dystrophy Type 2, Proximal Myotonic Myopathy

C. Angelini, 2014 .

Challenges and progress in the diagnosis of Congenital Muscular Dystrophies

C. Angelini, 2016 .

Measurement of D{0}-D[-over]{0} mixing from a time-dependent amplitude analysis of D{0}-->K+pi{-}pi{0} decays.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Evidence for D0-D0 mixing.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Measurement of D^0-D̅ ^0 mixing using the ratio of lifetimes for the decays D^0→K^-π^+ and K^+K^-

D. Leith, R. Field, K. Honscheid, 2008 .

Evidence for D-0-(D)over-bar(0) mixing

D. Leith, R. Field, K. Honscheid, 2007 .

Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report

A. Cerutti, C. Angelini, L. Giordano, 2010, Journal of Inherited Metabolic Disease.

“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy

L. Magliano, M. Pane, A. D’Amico, 2013, Journal of Neurology.

Branching fraction and CP asymmetries of B0-->K0(S)K0(S)K0(S).

G. J. Grenier, R. Kass, S. Bailey, 2005, Physical review letters.

Observation of the decay B̅ 0→Λc+p̅ π0

X. Chen, D. Leith, K. Honscheid, 2010 .

Glycogenosis Type 3, Cori-Forbes Disease

C. Angelini, 2014 .

Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.

R. Carrozzo, W. Engel, C. Angelini, 1993, The Journal of clinical investigation.

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies

C. Angelini, E. Pegoraro, L. Bello, 2016, Scientific Reports.

- 17-Advances and Perspectives in Muscular Dystrophies

C. Angelini, 2002 .

Measurement of the Ds→μνμ branching fraction and of the Ds decay constant

P. Mazzanti, D. Barberis, F. Ceradini, 2000 .

Measurement of the kinematic variables of beauty particles produced in 350 GeV/c π−-Cu interactions

P. Mazzanti, D. Barberis, F. Ceradini, 1999 .

production in 350 GeV/c π−-N interactions

P. Mazzanti, D. Barberis, F. Ceradini, 1999 .

Azimuthal correlation between beauty particles produced in 350 GeV/c π - -Cu interactions

P. Mazzanti, D. Barberis, F. Ceradini, 1998 .

A study of kinematical correlations between charmed particles produced in π-Cu interactions at GeV

P. Mazzanti, D. Barberis, F. Ceradini, 1996 .

Semileptonic B Decays and Determination of |V ub |

D. Leith, R. Field, K. Honscheid, 2005, hep-ex/0505070.

Measurement of decay amplitudes of B→J/ψK*, ψ(2S)K*, and χc1K* with an angular analysis

D. Leith, R. Field, James R. Wilson, 2007 .

Evidence for direct CP violation in the measurement of the Cabbibo-Kobayashi-Maskawa angle γ with B∓ → D(*)K(*)∓ decays.

D. Leith, R. Field, E. al., 2010, Physical review letters.

Branching fraction and charge asymmetry measurements in B -> J/psi pi pi decays RID A-8798-2012 RID C-5223-2009 RID C-5719-2008 RID D-1055-2009

Fry, Azzolini, Sordini, 2007 .

Measurement of the B0-->J/psipi+pi- branching fraction.

D. Leith, S. Schaffner, J. Beringer, 2002, Physical review letters.

Study of high-multiplicity three-prong and five-prong τ decays at BABAR

D. Leith, R. Field, K. Honscheid, 2012 .

Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect.

H. Reichmann, R. Carrozzo, C. Angelini, 1993, Japanese heart journal.

Childhood encephalomyopathy with cytochrome c oxidase deficiency, ataxia, muscle wasting, and mental impairment

N. Bresolin, C. Angelini, P. Rinaldo, 1986, Neurology.

The role of corticosteroids in muscular dystrophy: A critical appraisal

C. Angelini, 2007, Muscle & nerve.

Co-segregation of LMNA and PMP22 gene mutations in the same family

C. Angelini, E. Pegoraro, M. Mostacciuolo, 2005, Neuromuscular Disorders.

Heart involvement in muscular dystrophies due to sarcoglycan gene mutations

E. Hoffman, G. Danieli, C. Angelini, 1999, Muscle & nerve.

Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy

M. Mancuso, C. Angelini, G. Siciliano, 2010, Neuromuscular Disorders.

Measurement of the D*(2010)(+) natural linewidth and the D*(2010)(+)-D-0 mass difference

D. Leith, R. Field, K. Honscheid, 2013 .

Measurement of D 0-D 0 Mixing Parameters Using D 0 !

R. Field, K. Honscheid, D. Kirkby, 2010 .

Measurements of branching fractions, polarizations, and direct CP-violation asymmetries in B-->rhoK* and B-->f0(980)K* decays.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Measurement of CP Asymmetries and Branching Fractions in Charmless Two-Body B-Meson Decays to Pions and Kaons

D. Leith, R. Field, James R. Wilson, 2013 .

Measurement of time-dependentCPasymmetries inB0→D(*)±π∓andB0→D±ρ∓decays

D. Leith, M. Datta, R. Field, 2006, hep-ex/0602049.

Search for CP violation in B0-B0 mixing using partial reconstruction of B0→D*- Xℓ+ νℓ and a kaon tag.

R. Field, K. Honscheid, D. Kirkby, 2013, Physical review letters.

Study of CP violation in Dalitz-plot analyses of B[superscript 0]→K[superscript +]K[superscript -]K[subscript S][superscript 0], B[superscript +]→K[superscript +]K[superscript -]K[superscript +], and B[superscript +]→K[subscript S][superscript 0]K[subscript S][superscript 0]K[superscript +]

D. Leith, K. Honscheid, D. Kirkby, 2012 .

Measurements of the Absolute Branching Fractions of B ! KXc c

K. Honscheid, D. Kirkby, N. Roe, 2005, hep-ex/0510070.

Measurement of the absolute branching fraction of D0-->K-pi+.

D. Leith, R. Field, K. Honscheid, 1993, Physical review letters.

Dalitz plot analysis of D_s^+ → K^+K^-π^+

D. Leith, R. Field, K. Honscheid, 2009 .

Dalitz plot analysis of D_{s}^{+}→K^{+}K^{-}π^{+}

D. Leith, J. Smith, K. Honscheid, 2009 .

Measurement of angular asymmetries in the decays B -> K*l(+) l(+)

D. Leith, R. Field, K. Honscheid, 2016 .

First Observation of $CP$ Violation in $\bar{B}^{0}\rightarrow D^{(*)}_{CP} h^{0}$ Decays by a Combined Time-Dependent Analysis of BaBar and Belle Data

K. M. Williams, D. Leith, M. Feindt, 2015 .

Search for the decay modes B

M. S. Alam, D. Leith, K. Honscheid, 2012 .

Measurement of the branching fractions for the exclusive decays of B(0) and B(+) to D over-bar(*) D(*) K

V. R. Manfredi, D. Leith, M. Datta, 2002, hep-ex/0305003.

Observation of B;{0}-->K;(*0)K[over ](*0) and Search for B;(0)-->K;(*0)K;(*0).

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Measurement of D0-D0 mixing parameters using D0 → K(S)(0)π+ π- and D0 → K(S)(0)K+ K- decays.

R. Field, K. Honscheid, D. Kirkby, 2010, Physical review letters.

Measurement of the B0-->phiK*0 decay amplitudes.

R. Field, S. Bailey, K. Honscheid, 2004, Physical review letters.

Search for the decay B-0 -> J/psi gamma

Fry, Azzolini, Wagner, 2004 .

Search for B+→ϕπ+ and B0→ϕπ0 decays

D. Leith, M. Datta, R. Field, 2006 .

Measurement of D+(s) and D*+(s) production in B meson decays and from continuum e+ e- annihilations at s**(1/2) = 10.6-GeV.

Gill, Sokoloff, Harold S. Park, 2002 .

Measurements of the branching fractions of exclusive charmless B meson decays with eta(') or omega mesons.

S. Schaffner, M. Kunze, J. Beringer, 2001, Physical review letters.

Observation of B0-->omega K0, B+-->eta pi+, and B+-->eta K+ and study of related decays.

B. Brau, R. Field, S. Bailey, 2003, Physical review letters.

Rates, polarizations, and asymmetries in charmless vector-vector B meson decays.

D. Leith, B. Brau, R. Field, 2003, Physical review letters.

Measurements of CP-violating asymmetries and branching fractions in B meson decays to eta'K.

D. Leith, B. Brau, R. Field, 2003, Physical review letters.

First Observation of CP Violation in [bar over B][superscript 0] → D[(*) over CP]h[superscript 0] Decays by a Combined Time-Dependent Analysis of BABAR and Belle Data

K. M. Williams, D. Leith, M. Feindt, 2015 .

Measurement of time-dependent CP asymmetries and the CP-odd fraction in the decay B0-->D(*+)D(*-).

D. Leith, B. Brau, R. Field, 2007, Physical review letters.

Measurement of the $B^0$ meson lifetime with partial reconstruction of $B^0 \rightarrow D^{*-}\pi^+$ and $B^0 \rightarrow D^{*-}\rho^+$ decays

D. Leith, S. Schaffner, J. Beringer, 2003 .

Measurement of Time-Dependent $CP$ Asymmetries and the $CP$-odd Fraction in the Decay $B^0 \rightarrow D^{*+}D^{*-}$

D. Leith, S. Schaffner, J. Beringer, 2002 .

Measurements of branching fractions and CP-violating asymmetries in B0-->pi+pi-, K+pi-, K+K- decays.

D. Leith, S. Schaffner, J. Beringer, 2002, Physical review letters.

Measurement of the B0-B-0 oscillation frequency with inclusive dilepton events.

D. Leith, S. Schaffner, M. Kunze, 2001, Physical review letters.

Measurement of branching fractions for exclusiveBdecays to charmonium final states

D. Leith, S. Schaffner, M. Kunze, 2001, hep-ex/0107025.

Search for the decay $B^0 \rightarrow \gamma\gamma$

Re D. Del, D. Leith, S. Schaffner, 2001 .

A search for $\nu_{\mu} \rightarrow \nu_{\tau}$ oscillations using the NOMAD detector

B. Blumenfeld, P. Astier, M. Sevior, 1998 .

Study of B0→ρ+ρ- decays and constraints on the CKM angle α

D. Leith, R. Field, James R. Wilson, 2007 .

Charged hadron multiplicities in high energy $$\bar v_\mu n$$ and $$\bar v_\mu p$$ interactions

P. Mazzanti, J. Derkaoui, T. Bolognese, 1982 .

BABAR Silicon Vertex Tracker: Status and Prospects

M. Datta, D. Kirkby, N. Roe, 2006 .

Angular distributions in the decay B-- > K

K. Honscheid, D. Kirkby, R. Kass, 2009 .

Study of B-meson decays to eta_c K(*), eta_c(2S) K(*) and eta_c gamma K(*)

X. Chen, D. Leith, R. Field, 2008, 0804.1208.

Study of B-meson decays to eta K-c(*), eta(c)(2S)K(*), and eta(c)gamma K(*)

D. Leith, R. Field, K. Honscheid, 2008, 0804.1208.

Measurement of initial-state-final-state radiation interference in the processes e+e- →μ+μ-γ and e+e- →π+π-γ

D. Leith, R. Field, K. Honscheid, 2015 .

Study of e(+)e(-) -> p(p)over-bar via initial-state radiation at BABAR

D. Leith, R. Field, K. Honscheid, 2013 .

Initial-state radiation measurement of the e^{+}e^{-}→π^{+}π^{-}π^{+}π^{-} cross section

D. Leith, R. Field, K. Honscheid, 2012, 1201.5677.

Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR.

D. Leith, R. Field, K. Honscheid, 2009, Physical review letters.

Search for lepton-number violating B + → X -ℓ + ℓ ′ + decays

J. R. Wilson, D. Leith, R. Field, 2014 .

Measurements of CP-violating asymmetries in B0-->a1+/-(1260)pi-/+ decays.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Measurement of the spin of the omega(-) hyperon.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Production and decay of xi(c)(0) at BABAR.

S. Bailey, K. Honscheid, D. Kirkby, 2005, Physical review letters.

Search for B→K*νν decays

D. Leith, R. Field, K. Honscheid, 2008 .

Search for the charmed pentaquark candidate Θc(3100)0 in e+e- annihilations at s=10.58GeV

Fry, Azzolini, Wagner, 2006, hep-ex/0604006.

Measurement of the νμ and νμ nucleon charged-current total cross sections, and the ratio of νμ neutron to νμ proton charged-current total cross sections

A. G. Frodesen, M. Loreti, J. Derkaoui, 1984 .

Observation of new resonances decaying toD andD in inclusive eþe

D. Leith, R. Field, K. Honscheid, 2010 .

Search for f(J)(2220) in radiative J/ψ decays.

X. Chen, D. Leith, R. Field, 2010, Physical review letters.

A study of the EMC effect using neutrino and antineutrino interactions in neon and deuterium

A. G. Frodesen, T. Coghen, N. Eijndhoven, 1987 .

THE NOMAD EXPERIMENT AT THE CERN SPS The NOMAD Collaboration

B. Blumenfeld, P. Astier, M. Sevior, 1997 .

On the scaling violations of a thermodynamical valence quark distribution

C. Angelini, R. Pazzi, 1984 .

Branching fraction measurements of the color-suppressed decays (B)over-bar(0) to D-(*)0 pi(0), D-(*)0 eta, D-(*)0 omega, and D-(*)0 eta ' and measurement of the polarization in the decay (B)over-bar(0) -> D-(*)0 omega

R. Field, K. Honscheid, D. Kirkby, 2011 .

Measurement of the branching fraction, polarization, and CP asymmetries in B 0 ! (cid:1) 0 (cid:1) 0 decay, and implications for the CKM angle (cid:2)

R. Kass, D. Kirkby, M. Sokoloff, 2008 .

Erratum: Branching fraction measurements of the color-suppressed decays B̄0 to D(*)0π0, D (*)0η, D(*)0ω, and D (*)0η′ and measurement of the polarization in the decay B̄0→D*0ω (Physical Review D (2011) 84 (112007))

D. Leith, R. Field, K. Honscheid, 2013 .

Measurement of B-->K{*}(892)gamma branching fractions and CP and Isospin asymmetries.

D. Leith, R. Field, K. Honscheid, 2009, Physical review letters.

Searches for B meson decays to phiphi, phirho, phif_{0}(980), and f_{0}(980)f_{0}(980) final states.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Study of B+/ --> J/psi pi+/- and B+/ -->J/psi K+/- decays: measurement of the ratio of branching fractions and search for direct CP violation.

D. Leith, B. Brau, R. Field, 2004, Physical review letters.

Measurement of the neutral current coupling constants in neutrino and antineutrino interactions with deuterium

A. G. Frodesen, M. Loreti, J. Derkaoui, 1983 .

Proton and neutron structure functions from antineutrino interactions in deuterium

M. Loreti, P. Mazzanti, J. Derkaoui, 1982 .

Measurements of CP-violating asymmetries in B0-->K(0)(s)pi(0) decays.

D. Leith, B. Brau, R. Field, 2004, Physical review letters.

Duchenne muscular dystrophy. A population study.

G. Danieli, C. Angelini, M. Mostacciuolo, 1977, Human genetics.

Limb-Girdle Muscular Dystrophy with Epidermolysis Bullosa Simplex

C. Angelini, 2018 .

Long-term cyclosporine treatment in a group of severe myasthenia gravis patients

C. Angelini, D. Bonifati, 1997, Journal of Neurology.

Measurement of B --> K*gamma branching fractions and charge asymmetries.

Terece L. Turton, S. Schaffner, M. Kunze, 2001, Physical review letters.

Congenital muscular dystrophy: brain alterations in an unselected series of Western patients.

C. Angelini, C. Carollo, R. Giordano, 1991, Journal of neurology, neurosurgery, and psychiatry.

Search for T, CP, and CPT violation in B0-B0 mixing with inclusive dilepton events.

R. Kass, R. Field, K. Honscheid, 2006, Physical review letters.

New effects observed in the BaBar silicon vertex tracker: interpretation and estimate of their impact on the future performance of the detector

M. Datta, D. Kirkby, N. Roe, 2006, IEEE Nuclear Science Symposium Conference Record, 2005.

Lessons learned from BaBar silicon vertex tracker, limits, and future perspectives of the detector

M. Datta, D. Kirkby, N. Roe, 2004, IEEE Transactions on Nuclear Science.

Branching fraction measurement of B+→ωℓ +ν decays

Fry, Wagner, Alam, 2013 .

Evolution of cardiac involvement in progressive ophthalmoplegia with deleted mitochondrial DNA.

C. Angelini, G. Buja, P. Melacini, 1990, Japanese Heart Journal.

Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study

G. Vasco, C. Angelini, C. Montomoli, 2012, European Journal of Human Genetics.

State of the art in muscle glycogenoses

C. Angelini, Corrado Angelini, 2010, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Metabolic lipid muscle disorders: biomarkers and treatment

D. Tavian, S. Missaglia, C. Angelini, 2019, Therapeutic advances in neurological disorders.

Clinical and genetic characterization of Chanarin-Dorfman syndrome.

S. Dimauro, E. Bertini, A. D’Amico, 2008, Biochemical and biophysical research communications.

High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm

G. Bernardi, C. Angelini, C. Bruno, 2006, Neurological Sciences.

Skeletal Muscle Satellite Cells in Amyotrophic Lateral Sclerosis

C. Angelini, G. Soraru', G. Cenacchi, 2014, Ultrastructural pathology.

Enzyme Replacement Therapy for Pompe Disease

C. Angelini, C. Semplicini, 2012, Current Neurology and Neuroscience Reports.

Metabolic myopathies: the challenge of new treatments.

C. Angelini, C. Semplicini, 2010, Current opinion in pharmacology.

Direct CP violating asymmetry in B0-->K+pi- decays.

R. Field, S. Bailey, K. Honscheid, 2004, Physical review letters.

Search for B -> K-*nu(nu)overbar decays

Fry, Azzolini, Sordini, 2008 .

Amyotrophic lateral sclerosis with ragged-red fibers.

S. Dimauro, C. Angelini, H. Mitsumoto, 2008, Archives of neurology.

Regulation of Endoplasmic Reticulum-Mitochondria contacts by Parkin via Mfn2

C. Angelini, A. Antonini, M. Giacomello, 2018 .

Chapter 31: muscular dystrophy.

C. Angelini, 2010, Handbook of clinical neurology.

Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease

G. Comi, C. Angelini, C. Bruno, 2018, Neuromuscular Disorders.

Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings.

D. Tavian, S. Missaglia, C. Angelini, 2015, Molecular genetics and metabolism.

Erratum: The e+e-→2(π+π-)π0, 2(π+π-)η, K+K-π+π-π0 and K+K-π+π-η cross sections measured with initial-state radiation (Physical Review D - Particles, Fields, Gravitation and Cosmology (2007) 76, (092005))

D. Leith, R. Field, K. Honscheid, 2008 .

Transverse momentum of charged hadrons produced in ν and $$\bar v$$ deuterium charged current interactions

A. G. Frodesen, M. Loreti, N. Eijndhoven, 1985 .

Duchenne muscular dystrophy

G. Danieli, C. Angelini, M. Mostacciuolo, 2004, Human Genetics.

Exercise‐induced recurrent myoglobinuria

C. Angelini, G. Isaya, C. Trevisan, 1987, Neurology.

Malonyl-CoA abnormal inhibition of residual enzyme activity in carnitine palmitoyltransferase deficiency.

C. Angelini, G. Zacchello, G. Isaya, 1986, European neurology.

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.

G. L. Masson, W. Löscher, P. Vermersch, 2017, The Lancet. Neurology.

Charcot-Marie-Tooth Disease, Type X1

C. Angelini, 2014 .

Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.

L. Santoro, M. Zatz, C. Angelini, 2012, American journal of human genetics.

Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency

C. Angelini, C. Bruno, A. Anichini, 2011, Neurological research.

Improved measurement of the CKM angle gamma in B(-/+)-> D((*))K((*)-/+) decays with a Dalitz plot analysis of D decays to K(S)(0)pi(+)pi(-) and K(S)(0)K(+)K(-) RID C-5223-2009 RID C-5719-2008

Fry, Azzolini, Sordini, 2008 .

Cardiac transplantation in a Duchenne muscular dystrophy carrier

A. Angelini, G. Danieli, G. Thiene, 1998, Neuromuscular Disorders.

α-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations

E. Hoffman, C. Angelini, E. Pegoraro, 1996, Journal of the Neurological Sciences.

Heterogeneous Phenotypes in Lipid Storage Myopathy Due to ETFDH Gene Mutations.

D. Tavian, S. Missaglia, C. Angelini, 2017, JIMD reports.

Fatty Acid Mitochondrial Disorders

H. Reichmann, A. Federico, C. Angelini, 2010 .

Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders

H. Reichmann, A. Federico, C. Angelini, 2006, European journal of neurology.

Progress and challenges in diagnosis of dysferlinopathy

C. Angelini, M. Fanin, 2016, Muscle & nerve.

Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle.

G. Danieli, G. Thiene, C. Angelini, 2001, Transplantation proceedings.

Could utrophin rescue the myocardium of patients with dystrophin gene mutations?

G. Danieli, C. Angelini, M. Fanin, 1999, Journal of molecular and cellular cardiology.

Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: Characterization of sub-clinical phenotypes

C. Angelini, M. Cadaldini, E. Pegoraro, 1994, Neuromuscular Disorders.

Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition

S. Dimauro, C. Angelini, G. Basso, 2005, Neurology.

L-carnitine uptake in differentiating human cultured muscle.

C. Angelini, A. Martinuzzi, L. Vergani, 1991, Biochimica et biophysica acta.

Test of lepton universality in Υ(1S) decays at BABAR.

D. Leith, R. Field, K. Honscheid, 2010, Physical review letters.

Defective assembly of sarcoglycan complex in patients with β‐sarcoglycan gene mutations. Study of aneural and innervated cultured myotubes

C. Angelini, M. Fanin, 2002, Neuropathology and applied neurobiology.

Spastic Paraparesis Type 7

C. Angelini, 2014 .

Coenzyme Q10 Deficiency

C. Angelini, 2014 .

Dysferlin mutation analysis in a group of Italian patients with limb‐girdle muscular dystrophy and Miyoshi myopathy

Y. Hayashi, I. Nishino, C. Angelini, 2004, European journal of neurology.

Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism

C. Angelini, G. Cenacchi, M. Fanin, 2005, Journal of Clinical Pathology.

Missplicing of Troponin T transcripts in Myotonic dystrophy type 2 human biopsies

C. Angelini, A. Picard, M. Fanin, 2010 .

Investigation of exclusive channels in charged current interactions

A. G. Frodesen, A. Romero, G. Apeldoorn, 1990 .

Inclusive ϱ0 production in νμ D charged current interactions

A. G. Frodesen, M. Loreti, N. Eijndhoven, 1986 .

Fragmentation into strange particles in high energy vp, vn, vp and vn interactions

A. G. Frodesen, M. Loreti, J. Derkaoui, 1985 .

Fragmentation in neutrino and antineutrino charged current interactions on proton and neutron

A. G. Frodesen, M. Loreti, J. Derkaoui, 1984 .

Childhood dermatomyositis associated with intracranial tumor and liver cysts.

C. Angelini, Hanns Lochmüller, N. Barišić, 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Multifactorial study of inflammatory myopathies. Report of 29 cases

C. Angelini, M. Fanin, E. Menegazzo, 2006, The Italian Journal of Neurological Sciences.

Precision Measurement of the $B \to X_s \gamma$ Photon Energy Spectrum, Branching Fraction, and Direct CP Asymmetry $A_{CP}(B \to X_{s+d}\gamma)$

D. Leith, R. Field, James R. Wilson, 2012 .

Exclusive measurements of b → sγ transition rate and photon energy spectrum

D. Leith, R. Field, James R. Wilson, 2012 .

Precision measurement of the B → Xs γ photon energy spectrum, branching fraction, and direct CP asymmetry A(CP)((B → X(s+d)γ).

D. Leith, R. Field, K. Honscheid, 2012, Physical review letters.

Esophageal motor function in patients with myotonic dystrophy

M. Anselmino, C. Angelini, M. Costantini, 1996, Digestive Diseases and Sciences.

Carnitine, carnitine acyltransferases, and rat brain function

N. Bresolin, C. Angelini, L. Freddo, 1982, Experimental Neurology.

Measurement of the branching fraction and polarization for the decay B--->D*0K*-.

J. Beringer, B. Brau, R. Field, 2003, Physical review letters.

Determination of the branching fraction for B → X c ℓ decays and of

Fry, Azzolini, Wagner, 2004, hep-ex/0404017.

Search for b-->u transitions in B[superscript 0]-->D[superscript 0]K[superscript *0] decays

D. Leith, R. Field, K. Honscheid, 2009 .

Study of dipion bottomonium transitions and search for the h b(1P) state

D. Leith, R. Field, K. Honscheid, 2011 .

Measurement of the YY*--> pi 0 transition form factor

D. Leith, J. Smith, K. Honscheid, 2009 .

THERAPY AND PREVENTION PERIPHERAL ARTERIAL DISEASE

Tiziana, A. Policicchio, M. Chiariello, 2005 .

PERIPHERAL ARTERIAL DISEASE Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine : a double-blind , cross-over study

A. Policicchio, M. Chiariello, C. Angelini, 2005 .

ETF dehydrogenase advances in molecular genetics and impact on treatment

D. Tavian, S. Missaglia, C. Angelini, 2021, Critical reviews in biochemistry and molecular biology.

Dystrophin-positive myotubes in innervated muscle cultures from Duchenne and Becker muscular dystrophy patients

E. Hoffman, G. Danieli, C. Angelini, 1993, Neuromuscular Disorders.

Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients

G. Danieli, C. Angelini, L. Vitiello, 1992, Neuromuscular Disorders.

Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy

C. Angelini, B. Tavolato, M. Armani, 2007, Journal of Neurology.

Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis

C. Angelini, V. Nigro, W. Grisold, 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

L. Magliano, M. Pane, A. D’Amico, 2017, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Prenatal diagnosis in congenital muscular dystrophy

F. Muntoni, B. Brambati, C. Angelini, 1995, The Lancet.

Cardiomyopathy in a patient with limb-girdle muscular dystrophy type 2D: Pathomorphological aspects

C. Angelini, M. Fanin, M. Meznaric-Petrusa, 2009 .

Muscular dystrophy: Causes and management

C. Angelini, 2013 .

Study of B meson decays with excited eta and eta' mesons.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Observation of e(+)e(-) annihilation into the C = +1 hadronic final states rho(0)rho(0) and phirho(0).

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathy

D. Tavian, S. Missaglia, C. Angelini, 2019, Muscle & nerve.

Pregnancy , Labour and Delivery in Myotonic Dystrophy

C. Angelini, G. Novelli, G. Bonanni, 2007 .

Cognitive and psychiatric evaluation of 40 patients with myotonic dystrophy

C. Angelini, M. Armani, G. Perini, 1992, The Italian Journal of Neurological Sciences.

Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy

C. Angelini, M. Gennarelli, G. Bonanni, 2005, The Italian Journal of Neurological Sciences.

MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy

C. Angelini, E. Pegoraro, A. Vianello, 2007, Neuromuscular Disorders.

Correlation between clinical and molecular features in two MELAS families

S. Dimauro, R. Carrozzo, C. Angelini, 1992, Journal of the Neurological Sciences.

Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: Effect of propionyl‐L‐carnitine

R. Carrozzo, C. Angelini, M. Fanin, 1997, Muscle & nerve.

The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?

G. Comi, M. Zeviani, M. Mancuso, 2014, Journal of Neurology.

Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies.

C. Angelini, L. Nijtmans, A. Burlina, 1999, Brain : a journal of neurology.

SANDO (Sensory Ataxic Neuropathy, Dysarthria, Ophthalmoparesis)

C. Angelini, 2014 .

Dominant muscular dystrophy with a novel SYNE1 gene mutation

C. Angelini, A. Nascimbeni, V. Nigro, 2015, Muscle & nerve.

Detection of HTLV-I tax-rex and pol gene sequences of thymus gland in a large group of patients with myasthenia gravis.

C. Angelini, D. Bonifati, F. Giannini, 2002 .

Pompe Disease Diagnosis, Treatment, and Outcomes in Italy: Pompe Disease Registry Data from Italy Compared with the Rest-of-World

C. Angelini, S. Prasad, 2011 .

Late‐onset GSDII with novel GAA gene mutation

C. Angelini, A. Nascimbeni, A. Nascimbeni, 2007, Clinical genetics.

Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy

C. Angelini, M. Mostacciuolo, P. Perini, 1996, Human Genetics.

Congenital Muscular Dystrophy with Partial Merosin Deficiency and Late Onset Epilepsy

C. Angelini, C. Trevisan, F. Martinello, 1998, European Neurology.

Measurement of the *--> and *--> transition form factors

D. Leith, R. Field, K. Honscheid, 2011 .

The contemporary role of electron microscopy in neuromuscular pathology

G. Martinelli, C. Angelini, E. Pegoraro, 2008 .

Investigation of exclusive channels in neutrino / anti-neutrino deuteron charged current interactions

A. G. Frodesen, A. Romero, M. Turluer, 1990 .

Revisiting mitochondrial ocular myopathies: a study from the Italian Network

G. Comi, M. Zeviani, M. Mancuso, 2017, Journal of Neurology.

Measurement of the B0→D*-Ds*+ and Ds+→π+ branching fractions

D. Leith, R. Field, A. Soha, 2005 .

The Belle II silicon vertex detector assembly and mechanics

M. M. Kolwalkar, M. Friedl, F. Pilo, 2017 .

e(+)e(-)-> K+K-pi(+)pi(-), K+K-pi(0)pi(0) and K+K-K+K- cross sections measured with initial-state radiation RID C-5223-2009 RID C-5719-2008 RID D-1055-2009

Fry, Azzolini, Sordini, 2007 .

Observation of a broad structure in the pi+ pi- J/psi mass spectrum around 4.26 GeV/c2.

R. Kass, K. Honscheid, D. Kirkby, 2005, Physical review letters.

Evidence of a broad structure at an invariant mass of 4.32 GeV/c2 in the reaction e+e- --> pi+pi-psi(2S) measured at BABAR.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Observation of a narrow meson state decaying to D(+)(s)pi(0) at a mass of 2.32 GeV/c(2).

D. Leith, B. Brau, R. Field, 2003, Physical review letters.

Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

W. J. Brown, C. Angelini, S. Cederbaum, 1980, The New England journal of medicine.

An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis

C. Angelini, G. Siciliano, 2021, Expert review of neurotherapeutics.

Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells

V. Pertegato, C. Angelini, A. Casarín, 2012, Nature Protocols.

Clinical and Biochemical Aspects of Carnitine Deficiency and Insufficiency: Transport Defects and Inborn Errors of β-Oxidation

C. Angelini, A. Martinuzzi, L. Vergani, 1992 .

Plasma and Urine Carnitine Levels During Development

C. Angelini, L. Vergani, P. Battistella, 1980, Pediatric Research.

Myotonia and the muscle chloride channel

E. Hoffman, C. Angelini, M. Cadaldini, 1996, Neurology.

Decay time of light emission from cerium-doped scintillating glass

D. Crennell, C. Roda, C. Angelini, 1989 .

Facioscapulohumeral Muscular Dystrophy: A Multicenter Study on Hearing Function

C. Angelini, M. Ermani, P. Tonin, 2007, Audiology and Neurotology.

Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types.

C. Angelini, A. Engel, A. Engel, 1972, Archives of neurology.

Subcellular distribution of acid and neutral alpha-glucosidases in normal, acid maltase deficient, and myophosphorylase deficient human skeletal muscle.

C. Angelini, A. Engel, 1973, Archives of biochemistry and biophysics.

Nutritional Recommendations for Patients with Glycogen Storage Disease Type II

C. Angelini, 2008 .

EFNS review on the role of muscle biopsy in the investigation of myalgia

J. Burgunder, C. Angelini, G. Siciliano, 2013, European journal of neurology.

The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis

N. Bresolin, G. Comi, S. Corti, 2017, Muscle & nerve.

Mutations in the sarcoglycan genes in patients with myopathy.

E. Hoffman, C. Angelini, A. Berardinelli, 1997, The New England journal of medicine.

Dystrophinopathy in isolated cases of myopathy in females

E. Hoffman, J. Cook, R. Sakuta, 1992, Neurology.

Congenital Myofibrillar Myopathy Type 2

C. Angelini, 2018 .

Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1

C. Angelini, V. Pegoraro, C. Fritegotto, 2017, Neurological Sciences.

Fatal lipid storage with abnormal mitochondria in an infant.

C. Angelini, L. Vergani, P. Battistella, 1981, Acta neuropathologica. Supplementum.

Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients

D. Tavian, S. Missaglia, C. Angelini, 2020, European journal of translational myology.

Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency

D. Tavian, S. Missaglia, C. Angelini, 2018, Lipids in Health and Disease.

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

Pieter J. de Jong, Saeed Bohlega, Jing Liu, 1998, Nature Genetics.

Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies

C. Angelini, V. Pegoraro, 2021, Genes.

An update on diagnostic options and considerations in limb-girdle dystrophies

C. Angelini, R. Marozzo, Laura Giaretta, 2018, Expert review of neurotherapeutics.

Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F

C. Angelini, G. Siciliano, G. Piluso, 2013, PloS one.

Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes

C. Angelini, E. Pegoraro, A. Nascimbeni, 2009, Neurology.

Dysferlinopathy course and sportive activity: clues for possible treatment

C. Angelini, A. Gaiani, E. Peterle, 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations

C. Angelini, E. Ricci, G. Piluso, 2011, European Journal of Human Genetics.

How to tackle the diagnosis of limb-girdle muscular dystrophy 2A

C. Angelini, A. Nascimbeni, M. Fanin, 2009, European Journal of Human Genetics.

Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?

C. Angelini, G. Siciliano, G. Piluso, 2004, Human mutation.

Novel sarcoglycan gene mutations in a large cohort of Italian patients

C. Angelini, G. Siciliano, E. Pegoraro, 2003, Journal of medical genetics.

An intronic mutation causes severe LGMD2A in a large inbred family belonging to a genetic isolate in the Alps

C. Angelini, A. Nascimbeni, F. Benedicenti, 2012, Clinical genetics.

The clinical spectrum of sarcoglycanopathies

C. Angelini, G. Siciliano, M. Fanin, 1999, Neurology.

MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies

R. Stramare, C. Angelini, C. Angelini, 2010, La radiologia medica.

Muscle pathology in dysferlin deficiency

C. Angelini, M. Fanin, Corrado Angelini, 2002, Neuropathology and applied neurobiology.

Pathogenesis, clinical features and diagnosis of sarcoglycanopathies

C. Angelini, M. Fanin, 2016 .

Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy

L. Kunkel, R. Finkel, E. Hoffman, 1996 .

Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.

L. Kunkel, R. Finkel, E. Hoffman, 1996, Human molecular genetics.

Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures

Francesco Muntoni, Marika Pane, Vincenzo Nigro, 2005, Neuromuscular Disorders.

Improved diagnosis of Becker muscular dystrophy by dystrophin testing

L. Kunkel, E. Hoffman, M. Johnson, 1989, Neurology.

Congenital Nemaline Myopathy Type 1

C. Angelini, 2018 .

Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations

C. Angelini, A. Nascimbeni, M. Fanin, 2006, Journal of Medical Genetics.

Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy

K. Pelin, K. Bushby, F. Muntoni, 2006, Human mutation.

β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex

L. Kunkel, E. Hoffman, C. Bönnemann, 1995, Nature Genetics.

Congenital Myofibrillar Myopathy Type 5

C. Angelini, 2018 .

Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients

C. Angelini, L. Vergani, G. Soraru', 2007, Neuropathology and applied neurobiology.

Effects of combined endurance and resistance training in Amyotrophic Lateral Sclerosis: A pilot, randomized, controlled study

M. Cavinato, F. Piccione, C. Angelini, 2018, European journal of translational myology.

Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene.

G. Danieli, F. Muntoni, C. Angelini, 2002, Genomics.

Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2)

C. Angelini, A. Picard, M. Fanin, 2009, Neurological Sciences.

TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy.

E. Hoffman, C. Angelini, C. Heier, 2015, Cell reports.

Researchof microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients

C. Angelini, G. Novelli, A. Viola, 2010 .

Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin gene.

F. Muntoni, E. Calzolari, C. Angelini, 2006, Gene.

Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration

C. Angelini, A. Merico, V. Pegoraro, 2017, Journal of the Neurological Sciences.

Friedreich's disease

D. Bettis, C. Angelini, R. Sokol, 1987, Neurology.

The Role of Ultrastructural Examination in Storage Diseases

C. Angelini, E. Pegoraro, G. Cenacchi, 2010, Ultrastructural pathology.

Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis

A. Russell, C. Angelini, T. Ushida, 2013, Neurobiology of Disease.

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations

L. Santoro, C. Angelini, K. Claes, 2015, Neuromuscular Disorders.

Systemic Primary Carnitine Deficiency

C. Angelini, 2014 .

Recessive MYL2 mutations cause infantile type I muscle fibre disease and cardiomyopathy.

F. Baas, E. Aronica, C. Angelini, 2013, Brain : a journal of neurology.

Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells

C. Angelini, G. Novelli, M. Sandri, 2010, Cell Death and Differentiation.

Multiple Symmetric Lipomatosis

C. Angelini, 2014 .

Sensory, Motor, and Autonomic Neuropathy in Patients with Multiple Symmetric Lipomatosis

C. Angelini, M. Armani, D. Fedele, 1985, Medicine.

Phenotypic heterogeneity of the 8344A>G mtDNA “MERRF” mutation

G. Comi, M. Zeviani, M. Mancuso, 2013, Neurology.

Molecular characterization of myophosphorylase deficiency in a group of patients from Northern Italy

S. Dimauro, C. Angelini, M. Cadaldini, 1996, Journal of the Neurological Sciences.

Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.

C. Angelini, A. Naso, L. Vergani, 1981, The American journal of clinical nutrition.

Carnitine deficiency: Acute postpartum crisis

C. Angelini, E. Govoni, L. Vergani, 1978, Annals of neurology.

Carnitine deficiency of skeletal muscle

C. Angelini, S. Lucke, F. Cantarutti, 1976, Neurology.

CARNITINE DEFICIENCY INDUCED DURING HÆMODIALYSIS

C. Angelini, L. Vergani, M. Bertoli, 1978, The Lancet.

CARNITINE DEFICIENCY

C. Angelini, 1975, The Lancet.

Mitochondria-lipid-glycogen (MLG) disease of muscle. A morphologically regressive congenital myopathy.

C. Angelini, A. Engel, F. Jerusalem, 1973, Archives of neurology.

Adult acid maltase deficiency. Abnormalities in fibroblasts cultured from patients.

C. Angelini, A. Engel, J. Titus, 1972, New England Journal of Medicine.

Early ultrastructural and biochemical changes in muscle in dystrophia myotonica.

C. Angelini, S. Di Mauro, I. Mussini, 1970, Journal of the neurological sciences.

Adult acid maltase deficiency: an open trial with albuterol and branched- chain aminoacids

C. Angelini, E. Pegoraro, L. Vergani, 2004 .

Enzymes of the glycogen cycle and glycolysis in various human neuromuscular disorders.

C. Angelini, C. Catani, S. Di Mauro, 1967, Journal of neurology, neurosurgery, and psychiatry.

Fingerprint body myopathy, a newly recognized congenital muscle disease.

C. Angelini, A. Engel, M. Gomez, 1972, Mayo Clinic proceedings.

Recent advances and current clinical perspectives in the diagnosis and treatment of glycogenosis type II

C. Angelini, 2008, Neurology.

Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy

C. Angelini, R. Sacchetto, E. Damiani, 1996, Neuromuscular Disorders.

Measurement of the ratios of (−)νμn to (−)νμp at high energies

M. Loreti, P. Mazzanti, J. Derkaoui, 1981 .

Charged hadron multiplicities in high energy $$\bar v_\mu n$$ and $$\bar v_\mu p$$ interactions

P. Mazzanti, J. Derkaoui, T. Bolognese, 1982 .

Production of neutral strange particles in νμd2 and νμd2 charged current interactions

A. G. Frodesen, M. Loreti, P. Mazzanti, 1983 .

Search for a Δ(1236)−Δ(1236) structure of the deuteron

A. G. Frodesen, D. Gamba, I. Lippi, 1986 .

Bose-Einstein correlations in neutrino and antineutrino interactions in deuterium

A. G. Frodesen, J. Derkaoui, D. Gamba, 1988 .

Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats.

C. Angelini, B. Dallapiccola, A. Pizzuti, 1996, American journal of medical genetics.

Clinical and neuroimaging study of central nervous system in congenital myotonic dystrophy

C. Angelini, C. Trevisan, C. Trevisan, 1999, Journal of Neurology.

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy

E. Beghi, P. Tonali, C. Angelini, 1990, Journal of Neurology.

Assessment of the value of thymic scan in myasthenia gravis

C. Angelini, G. Testa, 1979, Journal of Neurology.

Quantitative histopathology in congenital myopathies.

C. Angelini, C. Trevisan, G. Micaglio, 1987, Rivista di neurologia.

Undiagnosed myopathy before surgery and safe anaesthesia table

A. Accorsi, C. Angelini, T. Mongini, 2013, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Gene expression profiling in dysferlinopathies using a dedicated muscle microarray.

Giorgio Valle, Chiara Romualdi, Marina Fanin, 2002, Human molecular genetics.

Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland

L. Peltonen, K. Baggerly, C. Angelini, 2011, European Journal of Human Genetics.

Positive correlation of CTG expansion and pharyngoesophageal alterations in myotonic dystrophy patients

C. Angelini, M. Ermani, G. Novelli, 1998, The Italian Journal of Neurological Sciences.

Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1

C. Angelini, G. Siciliano, C. Simoncini, 2020, Frontiers in Neurology.

Clinical and molecular characterization of limb‐girdle muscular dystrophy due to LAMA2 mutations

C. Angelini, E. Pegoraro, J. Vissing, 2011, Muscle & nerve.

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing

C. Angelini, 2015, Neurology: Genetics.

The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia

D. Guidolin, C. Angelini, S. Masiero, 2004, Journal of Gastrointestinal Surgery.

Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of beta-oxidation.

C. Angelini, A. Martinuzzi, L. Vergani, 1992, Critical reviews in clinical laboratory sciences.

Morphological study of TNPO3 and SRSF1 interaction during myogenesis by combining confocal, structured illumination and electron microscopy analysis

C. Angelini, N. Zini, C. Capanni, 2021, Molecular and Cellular Biochemistry.

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

G. Lanfranchi, C. Angelini, M. Ermani, 2010, Neurology.

Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial

N. Bresolin, C. Angelini, G. Scarlato, 1990, Journal of the Neurological Sciences.

Hereditary spastic paraplegia associated with peripheral neuropathy: a distinct clinical and genetic entity

C. Angelini, G. Vazza, L. Rampoldi, 2000, Neuromuscular Disorders.

Effects of Functional Electrical Stimulation Lower Extremity Training in Myotonic Dystrophy Type I: A Pilot Controlled Study

P. Kiper, F. Piccione, C. Angelini, 2016, American journal of physical medicine & rehabilitation.

Gender difference in limb-girdle muscular dystrophy: a muscle fiber morphometric study in 101 patients.

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Clinical neuropathology.

Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

C. Angelini, A. Nascimbeni, M. Fanin, 2003, The American journal of pathology.

A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy.

L. Mestroni, M. Giacca, F. Muntoni, 1996, Human molecular genetics.

Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.

C. Angelini, M. Fanin, D. Sandonà, 2008, The American journal of pathology.

Non-radioactive detection of 17p11.2 duplication in CMT1A: a study of 78 patients.

G. Danieli, C. Angelini, G. Siciliano, 1994, Journal of medical genetics.

Transcriptional and Translational Effects of Intronic CAPN3 Gene Mutations

C. Angelini, A. Nascimbeni, M. Fanin, 2010, Human mutation.

Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele

J. Zidar, C. Angelini, B. Peterlin, 2011, European journal of neurology.

Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north‐east Italian population sample

C. Angelini, G. Vazza, M. Mostacciuolo, 2009, Clinical genetics.

Familial polyglucosan body myopathy with unusual phenotype

C. Angelini, G. Cenacchi, V. Nigro, 2015, Neuropathology and applied neurobiology.

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study

G. Comi, E. Bertini, P. Striano, 2018, Orphanet Journal of Rare Diseases.

The genetic basis of undiagnosed muscular dystrophies and myopathies

G. Comi, E. Bertini, E. Mercuri, 2016, Neurology.

Charcot-Marie-Tooth Disease, Type 1A

C. Angelini, 2014 .

Hereditary Neuropathy with Pressure Palsies

C. Angelini, 2014 .

Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients

G. Comi, E. Bertini, E. Mercuri, 2018, Genes.

Identification of an intragenic deletion in the SGCB gene through a re-evaluation of negative next generation sequencing results

C. Angelini, G. Piluso, T. Giugliano, 2016, Neuromuscular Disorders.

Measurement of CP violation parameters with a Dalitz plot analysis of B{+/-}-->D{pi{+}pi{-}pi{0}}K{+/-}.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Heterogeneous pathogenesis of LGMD 2 : consequences for therapy

C. Angelini, A. Nascimbeni, M. Fanin, 2008 .

Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies

M. D'Esposito, F. Sera, L. Santoro, 2020, International journal of molecular sciences.

Ultrastructural changes in LGMD1F

C. Angelini, G. Cenacchi, M. Fanin, 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

Original A rticle Ultrastructural changes in LGMD1F

C. Angelini, G. Cenacchi, M. Fanin, 2012 .

Genetic epidemiology of myotonic dystrophy

C. Angelini, G. Barbujani, G. Danieli, 1987, Genetic epidemiology.

Clinical phenotype, muscle MRI and muscle pathology of LGMD1F

J. J. Padilla, C. Angelini, V. Nigro, 2013, Journal of Neurology.

Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients.

G. Danieli, C. Angelini, M. Mostacciuolo, 1992, Journal of medical genetics.

Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis

F. Sera, L. Santoro, C. Angelini, 2020, Scientific Reports.

A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes

F. Sera, L. Santoro, C. Angelini, 2016, Journal of Neurology.

Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

F. Sera, L. Santoro, C. Angelini, 2013, Brain : a journal of neurology.

A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

Gabriele Siciliano, Lucio Santoro, Leda Volpi, 2010, Muscle & nerve.

A 5-year clinical follow-up study from the Italian National Registry for FSHD

F. Sera, L. Santoro, C. Angelini, 2020, Journal of Neurology.

Steroids in muscular dystrophy: where do we stand?

C. Angelini, D. Bonifati, E. Pegoraro, 1998, Neuromuscular Disorders.

Calpain-3 and dysferlin protein screening in patients with limb–girdle dystrophy and myopathy

C. Angelini, E. Pegoraro, M. Fanin, 2001, Neurology.

Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A

C. Angelini, A. Nascimbeni, M. Fanin, 2007, Journal of Medical Genetics.

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy

A. Russell, C. Angelini, S. Lamon, 2014, Experimental physiology.

Redefining phenotypes associated with mitochondrial DNA single deletion

G. Comi, M. Zeviani, M. Mancuso, 2015, Journal of Neurology.

Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression.

E. Hoffman, C. Angelini, E. Pegoraro, 1999, Human molecular genetics.

“Mitochondrial neuropathies”: A survey from the large cohort of the Italian Network

G. Comi, M. Zeviani, M. Mancuso, 2016, Neuromuscular Disorders.

Liver fatty acid-binding protein in two cases of human lipid storage

R. Carrozzo, C. Angelini, A. Martinuzzi, 2004, Molecular and Cellular Biochemistry.

Multisystem triglyceride storage disorder with impaired long‐chain fatty acid oxidation

N. Bresolin, C. Angelini, M. Cantini, 1980, Annals of neurology.

Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents

C. Angelini, D. Bonifati, C. Rossi, 2000, Cancer Chemotherapy and Pharmacology.

Detection of HTLV‐I tax‐rex and pol Gene Sequences of Thymus Gland in a Large Group of Patients With Myasthenia Gravis

C. Angelini, D. Bonifati, F. Giannini, 2002, Journal of acquired immune deficiency syndromes.

Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy

E. Hoffman, C. Angelini, M. Cadaldini, 1995, Neurology.

LGMD. Identification, description and classification

C. Angelini, 2020, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship

F. Gianfrancesco, T. Esposito, L. del Viscovo, 2013, Orphanet Journal of Rare Diseases.

Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I

C. Angelini, E. Pegoraro, R. Manara, 2011, Journal of Neurology.

Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy

C. Angelini, A. Nascimbeni, M. Fanin, 2014, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Fatigue in muscular dystrophies

C. Angelini, Corrado Angelini, E. Tasca, 2012, Neuromuscular Disorders.

Sarcolemmal Neuronal Nitric Oxide Synthase Defect in Limb-Girdle Muscular Dystrophy: An Adverse Modulating Factor in the Disease Course?

C. Angelini, A. Nascimbeni, M. Fanin, 2009, Journal of neuropathology and experimental neurology.

Prevalent cardiac involvement in dystrophin Becker type mutation

C. Angelini, G. Siciliano, M. Fanin, 1994, Neuromuscular Disorders.

Fukuyama Congenital Muscular Dystrophy: Walker-Warburg Syndrome

C. Angelini, 2018 .

Erratum: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex (Nature Genetics (1995) 11 266-273))

L. Kunkel, E. Hoffman, C. Angelini, 1996 .

Postzygotic instability of the myotonic dystrophy p[AGC]n repeat supported by larger expansions in muscle and reduced amplifications in sperm

C. Angelini, B. Dallapiccola, A. Pizzuti, 1995, Journal of Neurology.

Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy.

G. Danieli, C. Angelini, B. Dallapiccola, 1995, Journal of the American College of Cardiology.

Population data on benign and severe forms of X-linked muscular dystrophy

C. Angelini, G. Danieli, C. Angelini, 1987, Human Genetics.

MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy

C. Angelini, V. Pegoraro, R. Marozzo, 2020, Diagnostics.

TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle

E. Hoffman, C. Angelini, M. Ermani, 2012, The Journal of pathology.

Absence of dystrophin and spectrin in regenerating muscle fibers from Becker dystrophy patients

C. Angelini, E. Pegoraro, M. Fanin, 1994, Journal of the Neurological Sciences.

Caspase 3 Expression Correlates With Skeletal Muscle Apoptosis in Duchenne and Facioscapulo Human Muscular Dystrophy. A Potential Target for Pharmacological Treatment?

C. Angelini, P. Schjerling, M. Sandri, 2001, Journal of neuropathology and experimental neurology.

Integrin α7β1 in Muscular Dystrophy/Myopathy of Unknown Etiology

E. Hoffman, E. Engvall, C. Angelini, 2002 .

Limb-Girdle Muscular Dystrophy Type 2I

C. Angelini, 2014 .

Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I

C. Angelini, E. Pegoraro, G. Cenacchi, 2007, Virchows Archiv.

Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.

C. Angelini, G. Siciliano, E. Pegoraro, 2005, Archives of neurology.

Clinical and Molecular Characterization of Patients With Limb-Girdle Muscular Dystrophy Type 2 I

C. Angelini, G. Siciliano, E. Pegoraro, 2005 .

CROSS-REACTIVE PROTEIN IN DUCHENNE MUSCLE

L. Kunkel, E. Hoffman, C. Angelini, 1989, The Lancet.

Novel mutations and polymorphisms in the human dystrophin gene detected by double‐strand conformation analysis

G. Danieli, C. Angelini, M. Mostacciuolo, 1997, Human mutation.

Regeneration in sarcoglycanopathies: expression studies of sarcoglycans and other muscle proteins

C. Angelini, M. Fanin, 1999, Journal of the Neurological Sciences.

Genetic epidemiology ofmuscular dystrophies resulting fromsarcoglycan genemutations

C. Angelini, M. Mostacciuolo, G. Soraru', 1997 .

The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy

E. Hoffman, C. Angelini, D. Bonifati, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Limb-Girdle Muscular Dystrophy Type 1C

C. Angelini, 2020, Definitions.

Calpain III mutation analysis of a heterogeneous limb–girdle muscular dystrophy population

C. Angelini, I. Hausmanowa-Petrusewicz, C. Greco, 1999, Neurology.

Enormous dystrophin in a patient with Becker muscular dystrophy

L. Kunkel, E. Hoffman, A. Beggs, 1990, Neurology.

RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance.

E. Hoffman, C. Angelini, E. Zammarchi, 1997, The Journal of clinical investigation.

Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation.

E. Hoffman, C. Angelini, E. Pegoraro, 1995, Human molecular genetics.

Spinal and bulbar muscular atrophy: Skeletal muscle pathology in male patients and heterozygous females

G. Moretto, C. Angelini, C. Gellera, 2008, Journal of the Neurological Sciences.

Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy

G. Lanfranchi, C. Angelini, A. Vettori, 2009, BMC medicine.

Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis.

R. Griggs, J. Mendell, P. Powers, 1997, Neuromuscular disorders : NMD.

Large-scale disruption of microtubule pathways in morphologically normal human spastin muscle

Y. W. Chen, E. Hoffman, S. Di Giovanni, 2004, Neurology.

Glycogenosis Type 4, Andersen Disease

C. Angelini, 2018 .

Cardiac involvement in Becker muscular dystrophy.

G. Danieli, C. Angelini, E. Pegoraro, 1993, Journal of the American College of Cardiology.

Hypokalemic Periodic Paralysis Type 1

C. Angelini, 2014 .

A new mutation in a family with cold-aggravated myotonia disrupts Na+ channel inactivation

C. Angelini, E. Pegoraro, M. Takahashi, 2001, Neurology.

Geographic distribution of hereditary myopathies in northeast Italy.

G. Danieli, C. Angelini, C. Vecchi, 1974, Social biology.

Systemic carnitine deficiency: a serious treatable inherited lipid storage disease presenting as recurrent Reye's syndrome

W. J. Brown, C. Angelini, P. Chapoy, 1980 .

Regulation of ER‐mitochondria contacts by Parkin via Mfn2

C. Angelini, A. Antonini, M. Giacomello, 2018, Pharmacological research.

HEREDITARY SPHEROCYTOSIS IN PERONEAL MUSCULAR ATROPHY

N. Bresolin, C. Angelini, M. Armani, 1978 .

Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients.

C. Angelini, G. Novelli, R. Massa, 2007, Genetic testing.

Reduction of the DM-associated homeo domain protein (DMAHP) mRNA in different brain areas of myotonic dystrophy patients

C. Angelini, B. Dallapiccola, G. Novelli, 1999, Neuromuscular Disorders.

Limits on the decay-rate difference of neutral B mesons and on CP, T, and CPT violation in B(0-0)B oscillations.

J. Beringer, B. Brau, R. Field, 2003, Physical review letters.

Search for a Dark Photon ine+e-Collisions atBaBar

D. Leith, R. Field, K. Honscheid, 2014, 1406.2980.

SuperB: A High-Luminosity Asymmetric e+e- Super Flavor Factory

H. Stoeck, G. Martinelli, Alfio Lazzaro, 2007 .

Search for the decay D 0

P. Mazzanti, C. Bacci, D. Barberis, 1995 .

Search for Long-Lived Particles in e+ e- Collisions.

D. Leith, R. Field, K. Honscheid, 2015, Physical review letters.

Search for the decay D0 ---> mu+ mu-

P. Mazzanti, A. Semenov, C. Bacci, 1995 .

Study of B-+/-,B-0 -> J/psi(K+K-K +/-,0) and search for B-0 -> J/psi phi at BABAR

D. Leith, R. Field, K. Honscheid, 2015 .

Travel to altitude with neurological disorders — recommendation of the UIAA Medical Commission

C. Angelini, G. Giardini, M. Falla, 2021, Health Promotion & Physical Activity.

Single pion production in charged current $$\bar vD$$ interactions at high energies

M. Loreti, J. Derkaoui, T. Bolognese, 1983 .

Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages

C. Angelini, G. Siciliano, S. Giannotti, 2015, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Authors’ reply

C. Angelini, E. Pinzan, 2019, Therapeutic advances in neurological disorders.

A study for the detection of ionizing particles with phototransistors on thick high-resistivity silicon substrates

M. G. Bisogni, M. Carpinelli, L. Ratti, 2004 .

Functional test of a Radon sensor based on a high-resistivity-silicon BJT detector

G. Verzellesi, C. Piemonte, L. Rovati, 2013 .

Study of the rare decays B0-->D((*)+)(s)pi(-) and B0-->D((*)-)(s)K+.

D. Leith, S. Schaffner, J. Beringer, 2003, Physical review letters.

Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1–3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry

F. Sera, L. Santoro, C. Angelini, 2016, BMJ Open.

Measurement of the inclusive charmless semileptonic branching ratio of B mesons and determination of |V ub|.

C Bozzi, E Robutti, L Lista, 2003, Physical review letters.

Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy

L. Santoro, D. Bruzzese, C. Angelini, 2020, JAMA network open.

Autoimmune neuromuscular disease induced by a preparation of choline acetyltransferase

C. Angelini, K. Kan, J. Keesey, 1982, Experimental Neurology.

Study of X(3915) --> J/\psi \omega\ in two-photon collisions

D. Leith, R. Field, James R. Wilson, 2012, 1207.2651.

Observation of the chi(c2)(2P) meson in the reaction gamma gamma -> D(D)over-bar at BABAR

D. Leith, R. Field, K. Honscheid, 2010 .

Observation of Y(3940) $\to J/\psi \omega$ in $B \to J/\psi \omega K$ at BABAR

X. Chen, D. Leith, R. Field, 2007, 0711.2047.

Measurement of the branching fractions of the radiative leptonic τ decays τ →eγν ν ¯ and τ →μγν ν ¯ at BABAR measurement of the branching fractions of the ... J.P. Lees et al

D. Leith, R. Field, K. Honscheid, 2015 .

Measurement of the Branching Fractions of the Radiative Leptonic τ Decays τ → eγν[bar over ν] and τ → μγν[bar over ν] at BABAR

D. Leith, R. Field, James R. Wilson, 2015 .

Measurement of Collins asymmetries in inclusive production of charged pion pairs in e^+e^- annihilation at BABAR

D. Leith, R. Field, K. Honscheid, 2014 .

MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

C. Angelini, Alfonc Baba, P. Cudia, 2020, Neurological Sciences.

Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy

C. Angelini, CORRADO ANGELINI, ENRICO PETERLE, 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Multiple Acyl-CoA Dehydrogenase Deficiency

C. Angelini, C. Angelini, 2014 .

Interpreting Genetic Variants in Titin in Patients With Muscle Disorders

Marika Pane, Claudio Bruno, Lucio Santoro, 2018, JAMA neurology.

Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders.

V. Pertegato, C. Angelini, M. Ermani, 2011, Mitochondrion.

Autonomic regulation in muscular dystrophy

C. Angelini, P. Cudia, R. di Leo, 2013, Front. Physiol..

Erratum to: Observation of interference correlations between like pions in the reaction $$\bar pp \to 2\pi ^ + 2\pi ^ - \pi ^0 $$ at low energyat low energy

M. Laloum, C. Angelini, L. Bertanza, 1977 .

Search for the rare decays B[superscript 0]→D[subscript s][superscript (*)+]a[-over subscript 0(2)]

D. Leith, M. Datta, R. Field, 2006 .

The BaBar Physics Book: Physics at an Asymmetric B Factory

E. Vallazza, Paola Grosso, A. Khan, 1998 .

Evidence for $CP$ violation in $B^{+} \to K^{*}(892)^{+} \pi^{0}$ from a Dalitz plot analysis of $B^{+} \to K^{0}_{\rm S} \pi^{+} \pi^{0}$ decays

Alam, Sokoloff, Giorgi, 2015 .

Measurement of Collins asymmetries in inclusive production of charged pion pairs in e[superscript +]e[superscript −] annihilation at BABAR

D. Leith, R. Field, James R. Wilson, 2014 .

Antideuteron production inϒ(nS)decays and ine+e−→qq¯ats≈10.58GeV

D. Leith, R. Field, K. Honscheid, 2014 .

Antideuteron production in ϒ(nS) decays and in e[superscript +]e[superscript −] → q[bar over q] at √s ≈ 10.58 GeV

D. Leith, R. Field, K. Honscheid, 2014 .

Measurement of CP-violating asymmetries in B0→(ρπ)0 decays using a time-dependent Dalitz plot analysis

Bjarne Stugu, Marco Bomben, Giovanni Calderini, 2013 .

Measurement of semileptonic B decays into orbitally excited charmed mesons.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Measurement of the branching fractions of exclusive _B-->D(*)(pi)l-_nu l decays in events with a fully reconstructed B meson.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Measurement of the branching fractions of B-->D**(l) nu(l) decays in events tagged by a fully reconstructed B meson.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Determination of the form factors for the decay B(0)-> D*(-)l(+)nu(l) and of the CKM matrix element vertical bar Vcb vertical bar RID C-5223-2009 RID C-5719-2008 RID D-1055-2009

Fry, Azzolini, Sordini, 2008 .

Measurement of the branching fractions of exclusive B̄ → D/D */D(*)πℓ-̄νℓ decays in events tagged by a fully reconstructed B meson

D. Leith, R. Field, K. Honscheid, 2007 .

Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients

C. Semenza, C. Angelini, E. Pegoraro, 2010, Neurological Sciences.

Dalitz-plot analysis of the decays B±→K±π∓π±

D. Leith, M. Datta, R. Field, 2005 .

Clinical and genetic characterization of an Italian family with slow-channel syndrome

C. Angelini, G. Vazza, M. Mostacciuolo, 2018, Neurological Sciences.

An amplitude analysis of the decay $B^\pm \to \pi^\pm \pi^\pm \pi^\mp$

Bjarne Stugu, I. Kitayama, Marco Bomben, 2005 .

Evidence for X(3872)-->psi(2S)gamma in B(+/-)-->X(3872)K(+/-) decays and a study of B-->cc[over ]gammaK.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Time-integrated and time-dependent angular analyses of B → J/ψKπ: A measurement of cos2β with no sign ambiguity from strong phases

D. Leith, R. Field, A. Soha, 2005 .

Measurement of time-dependent CP asymmetries in B0-->D(*)+/-D+/- decays.

S. Bailey, K. Honscheid, D. Kirkby, 2005, Physical Review Letters.

On the lifetime of charged charmed particles first direct observation of a charmed baryon decay

M. L. Ferrer, R. Sever, G. Ciapetti, 1979 .

Measurement Of The Muon-neutrino And Anti-muon-neutrino - Nucleon Charged Current Total Cross-sections, And The Ratio Of Muon-neutrino Neutron To Muon-neutrino Proton Charged Current Total Cross-section.

A. G. Frodesen, M. Loreti, J. Derkaoui, 1984 .

Search for direct CP violation in singly Cabibbo-suppressed D ±→K+K-π± decays

D. Leith, R. Field, K. Honscheid, 2012, 1212.1856.

B0 meson decays to ρ0K *0, f 0K *0, and ρ -K *+, including higher K * resonances

D. Leith, R. Field, James R. Wilson, 2012 .

Improved measurement of B+ --> rho+ rho0 and determination of the quark-mixing phase angle alpha.

D. Leith, R. Field, K. Honscheid, 2009, Physical review letters.

Measurement of J/psi production in continuum e(+)e(-) annihilations near square root of s = 10.6 GeV.

S. Schaffner, M. Kunze, J. Beringer, 2001, Physical review letters.

Observation of the Bottomonium Ground State in the Decay {upsilon}(3S){yields}{gamma}{eta}{sub b}

D. Leith, R. Field, K. Honscheid, 2008, 0807.1086.

Measurement of the D*(2010)+ meson width and the D*(2010)+ - D0 mass difference.

D. Leith, R. Field, K. Honscheid, 2013, Physical review letters.

Measurement of the branching fractions of the radiative leptonicτdecaysτ→eγνν¯andτ→μγνν¯atBABAR

D. Leith, R. Field, K. Honscheid, 2015 .

Measurements of direct CP asymmetries in B→Xsγ decays using sum of exclusive decays

D. Leith, R. Field, K. Honscheid, 2014 .

Search for B0 meson decays to π0KS0KS0, ηkS0KS0, and η′KS0KS0

X. Chen, D. Leith, R. Field, 2009 .

Measurement of the branching fraction andΛ¯polarization inB0→Λ¯pπ−

D. Leith, R. Field, K. Honscheid, 2009 .

Measurement of the semileptonic decaysB¯→Dτ−ν¯τandB¯→D*τ−ν¯τ

D. Leith, R. Field, K. Honscheid, 2009 .

Constraints on the CKM angleγinB0→D¯0K*0andB0→D0K*0from a Dalitz analysis ofD0andD¯0decays toKSπ+π−

D. Leith, R. Field, K. Honscheid, 2009 .

Study of B¯→ΞcΛ¯c- and B¯→Λc+Λ¯c-K¯ decays at BABAR

D. Leith, R. Field, J. Smith, 2008 .

Observation of the semileptonic decays B-->D*tau-nutau and evidence for B-->Dtau-nutau.

C Bozzi, E Robutti, L Lista, 2007, Physical review letters.

Search for decays of B0 mesons into e+e-, μ+μ- and e±μ final states

D. Leith, R. Field, K. Honscheid, 2008 .

Searches for B0 decays to ηk0, ηη, η′η′, η, and η′

Hee Chan Kim, R. Kass, D. Leith, 2006 .

Precise branching ratio measurements of the decays D-0 ->pi(-)pi(+)pi(0) and D-0 -> K-K+pi(0) relative to the D-0 -> K-pi(+)pi(0) decay

D. Leith, M. Datta, R. Field, 2006 .

Search for the decay B0→a1±ρ

D. Leith, M. Datta, R. Field, 2006 .

Status and prospects of the BaBar SVT

M. Datta, D. Kirkby, N. Roe, 2006 .

Search for the rare decays B^0 → D_s^((*)+)a-_(0(2))

Fry, Azzolini, Wagner, 2006 .

Search for radiative penguin decays B+ → ρ+γ,B0 → ρ0γ, and B0 → ωγ

D. Leith, R. Field, A. Soha, 2005 .

Search for the decay B+ --> K+nunu.

R. Field, S. Bailey, K. Honscheid, 2004, Physical review letters.

Sensor performance of the BABAR Silicon Vertex Tracker after 4 years of data taking

M. Datta, D. Kirkby, N. Roe, 2004 .

Radiation hardness and monitoring of the BaBar vertex tracker

R. Kass, B. Brau, M. Datta, 2004 .

Status and future plans of the BABAR silicon vertex tracker

M. Datta, D. Kirkby, N. Roe, 2003 .

Search for the Radiative Decays B → ργ and B0 → ωγ

D. Leith, J. Beringer, B. Brau, 2004 .

Search for the rare decays B-->Kl(+)l(-) and B-->K(*)l(+)l(-).

D. Leith, S. Schaffner, M. Kunze, 2002, Physical review letters.

Exclusive production of Ds+Ds-, Ds*+Ds-, and Ds*+Ds*- via e+e- annihilation with initial-state radiation

D. Leith, R. Field, James R. Wilson, 2010 .

Study of DsJ decays to D*K in inclusive e+e- interactions

D. Leith, R. Field, J. Smith, 2009 .

Muscle histopathology in upper motor neuron-dominant amyotrophic lateral sclerosis

F. Piccione, C. Angelini, E. Pegoraro, 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Measurement of cos2beta in B;{0}-->D;{(*)}h;{0} decays with a time-dependent Dalitz plot analysis of D-->K_{s};{0}pi;{+}pi;{-}.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Collins Asymmetries in Inclusive Charged KK and Kπ Pairs Produced in e⁺e⁻ Annihilation

D. Leith, R. Field, K. Honscheid, 2015 .

Observation of the decay B-->J/psietaK and search for X(3872)-->J/psieta.

D. Leith, B. Brau, R. Field, 2004, Physical review letters.

Measurement of time dependent CP asymmetry parameters in B0 meson decays to ω KS0, ν K0, and n0 KS0

D. Leith, R. Field, James R. Wilson, 2009 .

Measurements of branching fractions for B+→ρ+γ, B0→ρ0γ, and B0→ωγ

M. S. Alam, D. Leith, R. Field, 2008 .

Measurements of B --> {pi,eta,eta;{'}}lnu_{l} branching fractions and determination of |V_{ub}| with semileptonically tagged B mesons.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Observation of B+-->a1+(1260)K0 and B0-->a1-(1260)K+.

D. Leith, R. Field, K. Honscheid, 2008, Physical review letters.

Measurements of partial branching fractions for B-->Xulnu and determination of |Vub|.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Measurement of CP-Violating Asymmetries in the $B^0 \to K^{+} K^{-} K^0_{s}$ Dalitz Plot

Alam, Sokoloff, Mazur, 2008 .

Time-dependent dalitz plot analysis of B0→ K0Sπ+π-

D. Leith, R. Field, K. Honscheid, 2007 .

Search for the rare decay B-->pil+ l-.

R. Kass, D. Leith, R. Field, 2007, Physical review letters.

Measurements of CP-violating asymmetries in B0-->a1+/-(1260)pi-/+ decays.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Measurement of the B0-->pi(-l)(+nu) form-factor shape and branching fraction, and determination of /Vub/ with a loose neutrino reconstruction technique.

D. Leith, R. Field, K. Honscheid, 2006, Physical review letters.

Determination of |Vub| from measurements of the electron and neutrino momenta in inclusive semileptonic B decays.

R. Kass, S. Bailey, K. Honscheid, 2005, Physical review letters.

Time-dependent analysis ofB0→KS0π−π+γdecays and studies of theK+π−π+system inB+→K+π−π+γdecays

Fry, Wagner, Alam, 2015, 1512.03579.

Electronics and Firmware of the Belle II Silicon Vertex Detector Readout System

Takashi Kohriki, Satoshi Tanaka, Thomas Bergauer, 2018 .

Measurement of the CP Asymmetry Amplitude sin 2 with B 0 Mesons

J. Beringer, B. Brau, S. Bailey, 2002 .

using initial state radiation with BABAR

J. M. Tuggle, K. Honscheid, D. Kirkby, 2007 .

Measurements of the mass and width of the eta_c meson and of an eta_c(2S) candidate

R. Kass, J. Beringer, B. Brau, 2003, hep-ex/0311038.

Multicenter trial with ubidecarenone: treatment of 44 patients with mitochondrial myopathies.

N. Bresolin, G. Comi, C. Angelini, 1991, Revue neurologique.

Search for lepton flavor violating decays tau(+/-) --> l(+/-)pi0, l(+/-)eta, l(+/-)eta'.

D. Leith, R. Field, K. Honscheid, 2007, Physical review letters.

Study of the Decay B0(B̅ 0)→ρ+ρ-, and Constraints on the Cabibbo-Kobayashi-Maskawa Angle α

Fry, Azzolini, Wagner, 2004 .

Search for a low-mass higgs boson in Upsilon(3S)-->gammaA(0), A(0)-->tau(+)tau(-) at BABAR.

X. Chen, D. Leith, R. Field, 2009, Physical review letters.

Observation of Upsilon(4S) decays to pi(+)pi(-)Upsilon(1S) and pi(+)pi(-)Upsilon(2S).

R. Field, K. Honscheid, D. Kirkby, 2006, Physical review letters.

Measurement of the total width, the electronic width, and the mass of the Î¥(10580) resonance; ; Physical review. D, Particles, fields, gravitation, and cosmology;

Gill, D. Leith, B. Brau, 2005 .

Evidence of B-->tau nu decays with hadronic B tags

Bjarne Stugu, Marco Bomben, Giovanni Calderini, 2012, 1207.0698.

Search for CP violation in the decay τ^{-}→π^{-}K_{s}^{0}(≥Oπ^{0})ν_{τ}

D. Leith, J. Smith, K. Honscheid, 2012 .

Novel spastin mutations and their expression analysis in two Italian families

C. Angelini, E. Pegoraro, P. Montagna, 2003, European Journal of Human Genetics.

Search for lepton-flavor and lepton-number violation in the decay tau(-) -->l-(+)h+(-)h'(-).

R. Kass, S. Bailey, K. Honscheid, 2005, Physical review letters.

Search for fJ(2220) in Radiative J/psi Decays

R. Field, K. Honscheid, D. Kirkby, 2010 .

Genotype-phenotype correlation in Pompe disease, a step forward

C. Angelini, G. Siciliano, P. Tonin, 2014, Orphanet Journal of Rare Diseases.

Disorders of lipid metabolism.

C. Angelini, 2007, Handbook of clinical neurology.

High-resolution tracking with scintillating fibres

D. Crennell, C. Roda, C. Angelini, 1989 .

Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases

G. Comi, M. Zeviani, M. Mancuso, 2012, Neuromuscular Disorders.

Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2

G. Bernardi, G. Meola, C. Angelini, 2008, Muscle & nerve.

Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency.

H. Reichmann, C. Angelini, C Angelini, 1994, European neurology.

Cerebellar ataxia and coenzyme Q10 deficiency

D. Lynch, S. Dimauro, E. Bertini, 2003, Neurology.

S2.1 Enzyme replacement therapy (ERT) in Glycogen Storage Disease Type II: the first treatment developed

C. Angelini, E. Pegoraro, A. Nascimbeni, 2011, Acta Myologica.

Parkinson-like features in ALS with predominant upper motor neuron involvement

C. Angelini, A. Cagnin, L. Santelli, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT‐II deficiency

A. D’Amico, C. Angelini, G. Siciliano, 2012, Clinical genetics.

Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study

C. Angelini, A. Martinuzzi, C. Macchi, 2006, European journal of neurology.

Microglia polarization by mitochondrial metabolism modulation: A therapeutic opportunity in neurodegenerative diseases.

C. Angelini, A. Di Stadio, 2019, Mitochondrion.

MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients.

C. Angelini, V. Pegoraro, R. Marozzo, 2020, Clinical neuropathology.

Title Measurement of the D 0 → π-e + νe differential decay branching fraction as a function of q 2 and study of form factor

M. S. Alam, D. Leith, R. Field, 2015 .

Search for CP violation using Todd correlations in D + → K

D. Leith, R. Field, K. Honscheid, 2011 .

Search for CP violation using Todd correlations in D [ superscript 0 ]

R. Field, K. Honscheid, D. Kirkby, 2010 .

Search for CP violation using Todd correlations in D þ !

D. Leith, R. Field, K. Honscheid, 2010 .

Title Search for CP violation using Todd correlations in D 0 → K + K-π + π-decays Permalink

R. Field, K. Honscheid, D. Kirkby, 2010 .

Dalitz plot analysis of Ds+→π+π-π+

K. Honscheid, D. Kirkby, R. Kass, 2009 .

Measurement of the hadronic form factor in D-0 -> K(-)e(+)nu(e) decays RID C-5223-2009 RID C-5719-2008 RID D-1055-2009

Fry, Azzolini, Sordini, 2007 .

Impaired copper and iron metabolism in blood cells and muscles of patients affected by copper deficiency myeloneuropathy

C. Angelini, L. Salviati, M. Spinazzi, 2014, Neuropathology and applied neurobiology.

Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy

P. Zaniol, B. Barbiroli, R. Lodi, 1995, Journal of the Neurological Sciences.

Study of CP-violating asymmetries in B-0 ->pi(+) pi(-), K+ pi(-) decays

Fry, Brigljevic, Wagner, 2002 .

The Belle II SVD data readout system

M. M. Kolwalkar, K. Nakamura, M. Friedl, 2017 .

Male Hypogonadism in Myotonic Dystrophy is Related to (Ctg)N Triplet Mutation

C. Angelini, B. Dallapiccola, G. Novelli, 1994, Journal of endocrinological investigation.

Amyotrophic Lateral Sclerosis Type 2, Juvenile

C. Angelini, 2018 .

Measurements of the branching fraction and CP-violation asymmetries in B0-->f0(980)K0S.

B. Brau, R. Field, S. Bailey, 2004, Physical Review Letters.

Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients.

T. Crawford, E. Hoffman, R. Zimmerman, 1998, Neurology.

Divergence of central nervous system involvement in 2 Italian sisters with congenital muscular dystrophy: a clinical and neuroradiological follow-up.

C. Angelini, E. Ferruzza, C. Trevisan, 1995, European neurology.

Surveys of Progress Lipid Storage Myopathies *

C. Angelini, 2022 .

LAMA2 loss-of-function mutation in a girl with a mild congenital muscular dystrophy

C. Angelini, A. Pichiecchio, E. Pegoraro, 2004, Neurology.

Myopathy with tubular aggregates and hypertrophic cardiomyopathy in a patient with type IIA von Willebrand disease.

C. Angelini, A. Girolami, M. Mareš, 1996, Haematologia.

Incomplete penetrance in limb‐girdle muscular dystrophy type 1F

C. Angelini, A. Nascimbeni, A. Torella, 2015, Muscle & nerve.

Association Between Human Polymorphic DNA Markers and Hypoxia Adaptation in Sherpa Detected by a Preliminary Genome Scan

G. Danieli, C. Angelini, M. Ota, 2007, Annals of human genetics.

Discordant clinical outcome in myotonic dystrophy relatives showing (CTG) n > 700 repeats

C. Angelini, B. Dallapiccola, G. Novelli, 1995, Neuromuscular Disorders.

C. Angelini, V. Nigro, M. Fanin, 2016, Muscle & nerve.

Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2

C. Angelini, M. Ermani, G. Novelli, 2010, Journal of Neurology.

The prognosis and main prognostic indicators of GuillainBarré syndrome. A multicentre prospective study of 297 patientsThe Italian Guillain-Barré Study GroupBrain1996119205320619010009

E. Beghi, P. Tonali, C. Angelini, 1996 .

Congenital Fiber-Type Disproportion

C. Angelini, 2014 .

Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study

M. Cosottini, C. Angelini, G. Siciliano, 2016, Orphanet Journal of Rare Diseases.

LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population

G. Comi, C. Angelini, G. Iorio, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC Consortium

C. Angelini, 2021, European journal of translational myology.

Looking for an Early Diagnosis in a Late Onset Pompe Disease High Risk Population: A LOPED Study (P3.015)

G. Comi, C. Angelini, G. Iorio, 2014 .

Myoglobinuria and carnitine palmityltransferase (CPT) deficiency

C. Angelini, A. Martinuzzi, L. Freddo, 1984, Neurology.

Carnitine palmityl transferase deficiency

N. Bresolin, C. Angelini, M. Armani, 1981, Neurology.

Carnitine Palmitoyltransferase II Deficiency

C. Angelini, 2014 .

Study of T and CP violation in B0 and anti-B0 mixing with inclusive dileption events

E. Vallazza, Zongfu Yu, Paola Grosso, 2001 .

Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy

E. Bertini, G. Comi, C. Angelini, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Natural history of upper motor neuron-dominant ALS

G. Logroscino, C. Angelini, M. Ermani, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

A Search for Dark Higgs Bosons

D. Leith, R. Field, K. Honscheid, 2012, 1202.1313.

Erratum: Observation of the bottomonium ground state in the decay Υ(3S)→γηb (Physical Review Letters (2008) 101 (071801))

D. Leith, R. Field, K. Honscheid, 2009 .

Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS.

C. Angelini, A. Merico, E. Tasca, 2016, Clinical neuropathology.

Antideuteron production in (nS) decays and in e+e- →q q ̄ at s ≈10.58GeV antideuteron production in (nS) ⋯ J.P. LEES et al.

D. Leith, R. Field, K. Honscheid, 2014 .

Observation of Υ(4S) Decays to π+π-Υ(1S) and π+π-Υ(2S)

D. Leith, M. Datta, R. Field, 2006 .

Molecular update and therapeutic trials in muscle disorders of glycogen and lipid metabolism

C. Angelini, 2003 .

The BaBar Silicon Vertex Tracker: Performance and radiation damage studies

Giovanni Calderini, F. Goozen, G. Della Ricca, 2004 .

GYG1 gene mutations in a family with polyglucosan body myopathy

C. Angelini, A. Torella, V. Nigro, 2015, Neurology: Genetics.

Bottomonium spectroscopy and radiative transitions involving the [ subscript bJ ] ( 1 P , 2 P ) states

M. S. Alam, D. Leith, R. Field, 2014 .

Limb-Girdle Muscular Dystrophy Type 2K

C. Angelini, 2014 .

Congenital Tubular Aggregate Myopathy

C. Angelini, 2014 .

New treatments for myasthenia: a focus on antisense oligonucleotides

C. Angelini, S. Martignago, M. Bisciglia, 2013, Drug design, development and therapy.

Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1

I. Pesaresi, M. Cosottini, U. Bonuccelli, 2016, NeuroImage: Clinical.

Right hemisphere dysfunction and emotional processing in ALS: an fMRI study

C. Semenza, C. Volpato, C. Angelini, 2010, Journal of Neurology.

Pilot trial of clenbuterol in spinal and bulbar muscular atrophy

C. Angelini, M. Ermani, E. Pegoraro, 2013, Neurology.

Slow-Channel Congenital Myasthenic Syndrome

C. Angelini, 2014 .

Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E

C. Angelini, A. Nascimbeni, M. Fanin, 2006, Neuromuscular Disorders.

Limb-Girdle Muscular Dystrophy Type 2A

C. Angelini, 2014 .

gene mutations CAPN3 muscle: a functional map of Screening of calpain-3 autolytic activity in LGMD

C. Angelini, A. Nascimbeni, M. Fanin, 2007 .

Limb-Girdle Muscular Dystrophy Type 2B

C. Angelini, 2020, Definitions.

Lipid storage myopathies

C. Angelini, Corrado Angelini, 1976, Journal of Neurology.

Glycogenosis Type 7, Tarui Disease

C. Angelini, 2018 .

Diagnostic Approach to Pauci-or Asymptomatic hyperCKemia

C. Angelini, G. Siciliano, S. Sacconi, 2011 .

Limb-Girdle Muscular Dystrophy Type 2T

C. Angelini, 2018 .

The Italian LGMD registry : relative frequency , clinical features , and differential diagnosis

Tiziana, N. Bresolin, G. Comi, 2016 .

Erratum: Search for the rare leptonic decay B+ → μ+νμ (Physical Review Letters (2004) 92 (221803))

D. Leith, J. Beringer, B. Brau, 2004 .

Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment

N. Bresolin, C. Angelini, M. Armani, 2004, Journal of Neurology.

Current and emerging therapies in Becker muscular dystrophy (BMD)

C. Angelini, V. Pegoraro, R. Marozzo, 2019, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

McArdle disease: the mutation spectrum of PYGM in a large Italian cohort

F. Zara, C. Angelini, C. Bruno, 2006, Human mutation.

Study of B̄→X ulν decays in BB events tagged by a fully reconstructed B-meson decay and determination of |V ub|

D. Leith, R. Field, K. Honscheid, 2012 .

Bottomonium spectroscopy and radiative transitions involving the χ bJ ð 1 P ; 2 P Þ states at

D. Leith, R. Field, K. Honscheid, 2014 .

Title Measurements of branching fractions for B + → ρ + γ , B 0 → ρ 0 γ , and B 0 → ωγ Permalink

K. Honscheid, D. Kirkby, R. Kass, 2008 .

Niemann-Pick Disease Type C1

C. Angelini, 2014 .

Observation of the decay B± → π±π0, study of B± → K±π0, and search for B0 → π0 π0

D. Leith, B. Brau, M. Datta, 2003 .

Measurements of branching fractions and CP-violating asymmetries in B0-->rho(+/-)h(-/+) decays.

D. Leith, J. Beringer, B. Brau, 2003, Physical review letters.

Measurement of CP-Violating Asymmetries in the $B^0 \to K^+K^-K^0$ Dalitz Plot

Re D. Del, D. Leith, M. Datta, 2006 .

Observation of the Semileptonic Decays B→D^{*}τ^{-}ν[over ¯]_{τ} and Evidence for B→Dτ^{-}ν[over ¯]_{τ}

D. Leith, R. Field, K. Honscheid, 2008 .

Congenital Centronuclear Myopathy Type 1

C. Angelini, 2014 .

Occurrence of two different intragenic deletions in two male relatives affected with Duchenne muscular dystrophy.

G. Danieli, C. Angelini, M. Mostacciuolo, 1994, American journal of medical genetics.

European Federation of the Neurological Societies guidelines on the diagnostic approach to paucisymptomatic or asymptomatic hyperCKemia

C. Angelini, D. Hilton‐Jones, T. Kyriakides, 2020 .

Chronic Progressive External Ophthalmoplegia

C. Angelini, 2014 .

A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron

G. Danieli, C. Angelini, M. Mostacciuolo, 1994, Human Genetics.

Measurement of the B0→π-ℓ+ν and B+→η(′)ℓ+ν branching fractions, the B0→π-ℓ+ν and B+→ηℓ+ν form-factor shapes, and determination of |Vub|

D. Leith, R. Field, K. Honscheid, 2011 .

Search for dimuon decays of a light scalar boson in radiative transitions Upsilon-->gammaA0.

C Bozzi, E Robutti, L Lista, 2009, Physical review letters.

Evidence for B+ --> K0K+ and B0 --> K0K0, and measurement of the branching fraction and search for direct CP violation in B+ --> K0pi+.

R. Kass, K. Honscheid, D. Kirkby, 2005, Physical review letters.

Measurement of the inclusive charmless semileptonic branching ratio of B mesons and determination of vertical bar V-ub vertical bar RID A-8798-2012 RID C-2728-2008 RID C-5223-2009 RID C-5719-2008 RID D-1055-2009 RID A-2675-2009

Fry, Brigljevic, Wagner, 2004 .

Limb-Girdle Muscular Dystrophy Type 2H

C. Angelini, 2018 .

Remodel mitochondria and get energized

C. Angelini, J. Vissing, 2018, Neurology.

Metabolites-mitochondria-macrophages (MMM): new therapeutic avenues for inflammation and muscle atrophy

C. Angelini, 2017 .

Metabolites-Mitochondria-Microglia (Mmma): Therapeutic Stategy for Treatment of Neural Inflammation and Neurodegeneration

Arianna Di Stadio, C. Angelini, 2018, Journal of Molecular Biomarkers & Diagnosis.

Plasmapheresis in the treatment of myasthenia gravis

C. Angelini, G. Micaglio, M. Belloni, 1988 .

Congenital Myasthenic Syndrome Type 11

C. Angelini, 2018 .

Enzymes oftheglycogen cycle andglycolysis in various humanneuromuscular disorders

C. Angelini, S. Mauro, 1967 .

neuromuscular disorders . and glycolysis in various human Enzymes of the glycogen cycle

C. Angelini, C. Catani, S. Mauro, 2022 .

EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia.

David Hilton-Jones, C. Angelini, Corrado Angelini, 2019, Muscle and Nerve.

Design and characterization of integrated front-end transistors in a micro-strip detector technology

Maurizio Boscardin, Nicola Zorzi, Massimo Manghisoni, 2002 .

Quality of life and motor impairment in ALS: Italian validation of ALSAQ

C. Angelini, M. Ermani, E. Pegoraro, 2010, Neurological research.

Subacute sensory ataxia and optic neuropathy with thiamine deficiency

C. Patrini, C. Angelini, M. Spinazzi, 2010, Nature Reviews Neurology.

MicroRNAs are appropriate in mitochondrial related hearing loss? Answer to the skepticism

C. Angelini, A. Di Stadio, 2018, Orphanet Journal of Rare Diseases.

Hearing impairment in MELAS: new prospective in clinical use of microRNA, a systematic review

L. Dipietro, C. Angelini, A. Di Stadio, 2018, Orphanet Journal of Rare Diseases.

A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy.

E. Hoffman, C. Angelini, E. Pegoraro, 2000, Neurology.

A high-resolution tracking detector based on capillaries filled with liquid scintillator

D. Lucchesi, R. Nahnhauer, P. Lendermann, 1992 .

P.5.10 Clinical and ultrastructural changes in transportinopathy

C. Angelini, G. Cenacchi, V. Nigro, 2013, Neuromuscular Disorders.

Relationship of serum enzyme changes to muscle damage in vitamin E deficiency of the rabbit.

C. Angelini, S. Di Mauro, A. Margreth, 1968, Lo sperimentale.

MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts.

I. Nonaka, C. Angelini, A. Martinuzzi, 1992, Proceedings of the National Academy of Sciences of the United States of America.

from events with initial-state radiation

M. S. Alam, D. Leith, R. Field, 2014 .

EPIDEMIOLOGY OF MYOTONIC DYSTROPHY IN ITALY

C. Angelini, G. Siciliano, A. Iudice, 2001 .

Search for lepton-flavor violating decays of tau to lepton+photon, eta or eta'

D. Leith, R. Field, E. al., 2006, hep-ex/0610067.

Limb-Girdle Muscular Dystrophy Type 2C

C. Angelini, 2014 .

The genetic basis of undiagnosed muscular dystrophies and myopathies: Results from 504 patients

L. Wilkins, G. Comi, E. Bertini, 2016, Neurology.

Neuromuscular disease: Diagnosis and discovery in limb-girdle muscular dystrophy

C. Angelini, 2016, Nature Reviews Neurology.

Prevalence of unsuspected myopathy in infants presenting for clubfoot surgery

G. Pittoni, C. Angelini, G. Zanette, 1995, Paediatric anaesthesia.

Neonatal spinal muscular atrophy with diaphragmatic paralysis is unlinked to 5q11.2-q13.

C. Angelini, B. Dallapiccola, G. Novelli, 1995, Journal of medical genetics.

Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot-Marie-Tooth disease type 1.

G. Danieli, C. Angelini, M. Mostacciuolo, 1995, Neuroepidemiology.

Sphingomonas paucimobilis associated with localised calf myositis

C. Angelini, G. Palù, E. Pegoraro, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Mitochondrial Complex I Deficiency due to ACAD9 Deficiency

C. Angelini, 2018 .

Measurement of D^0-D^0 mixing and CP violation in two-body D^0 decays

D. Leith, R. Field, K. Honscheid, 2012, 1209.3896.

Measurement of D 0D 0 mixing parameters using D 0 → K 0 S π + π − and D 0 → K 0 S K + K − decays

K. Honscheid, D. Kirkby, R. Kass, 2010 .

Measurements of the Semileptonic Decays anti-B ---> D l anti-nu and anti-B ---> D* l anti-nu Using a Global Fit to D X l anti-nu Final States

Mazur, Saeed, Giorgi, 2008 .

Myomirnas Role in Als Suggest a Crosstalk between Muscle and Motor Neuron

C. Angelini, A. Merico, V. Pegoraro, 2018 .

Cross Sections for the Reactions e

M. S. Alam, D. Leith, R. Field, 2014 .

WA92: A fixed target experiment to study beauty in hadronic interactions

P. Mazzanti, C. Bacci, R. Cardarelli, 1992 .

Serum lipids, lipoprotein analysis and apoprotein A-I, A-II and B levels in Friedreich's ataxia.

C. Angelini, G. Crepaldi, R. Fellin, 1990, European neurology.

Measurement of the gamma gamma* -> eta c transition form factor RID C-5223-2009

Fry, Azzolini, Sordini, 2009 .

Facioscapulohumeral Muscular Dystrophy Type 1A

C. Angelini, 2014 .

Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy

G. Lanfranchi, C. Angelini, A. Vettori, 2009, BMC medicine.

Spinal Muscular Atrophy Type 2, Werdnig-Hoffmann Disease

C. Angelini, 2014 .

Spinal Muscular Atrophy Type 1, Werdnig-Hoffmann Disease

C. Angelini, 2014 .

Expression profiling characterization of laminin alpha-2 positive MDC.

G. Lanfranchi, C. Angelini, E. Pegoraro, 2006, Biochemical and biophysical research communications.

Neuromuscular diseases: advances in therapy and diagnosis

C. Angelini, 2012, The Lancet Neurology.

MELAS (Myopathy, Encephalopathy, Lactic Acidosis, Stroke-like Episodes)

C. Angelini, 2014 .

TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy.

E. Hoffman, C. Angelini, C. Heier, 2015, Cell reports.

Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis

C. Angelini, T. Ushida, B. Léger, 2013, Neurobiology of Disease.

MyomiRNAs Dysregulation in ALS Rehabilitation

C. Angelini, A. Merico, V. Pegoraro, 2019, Brain sciences.

The Monitoring System of the Belle II Vertex Detector

M. M. Kolwalkar, K. Hara, M. Friedl, 2017 .

Impaired copper and iron metabolism in blood cells and muscles of patients affected by copper deficiency myeloneuropathy

C. Angelini, L. Salviati, M. Spinazzi, 2014, Neuropathology and applied neurobiology.

Antideuteron production in (nS) decays and in e+e- →q q ̄ at s ≈10.58GeV antideuteron production in (nS) ⋯ J.P. LEES et al.

D. Leith, K. Honscheid, R. Kass, 2014 .

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy

A. Russell, C. Angelini, S. Lamon, 2014, Experimental physiology.

Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

L. Magliano, M. Pane, A. D’Amico, 2017, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Prevention of cardiomyopathy in Duchenne muscular dystrophy

C. Angelini, 2015, The Lancet Neurology.

Congenital Central Core Myopathy with Malignant Hyperthermia

C. Angelini, 2014 .

Search for the rare decay $D^0 \to μ^+ μ^-$

Gibson, Rangel, Fave, 2013 .

Measurement of angular asymmetries in the decays B → K[superscript *]ℓ[superscript +]ℓ[superscript −]

D. Leith, K. Honscheid, R. Kass, 2016 .

Dalitz-plot analysis of the decays B+/- -->K+/- pi-/+ pi+/-

Fry, Azzolini, Wagner, 2005, hep-ex/0507004.

Measurement of CP-violating asymmetries in B^0 --> K^0s pi^0 decays.

D. Leith, B. Brau, S. Bailey, 2004 .

Polyglucosan Body Myopathy Type 2

C. Angelini, 2018 .

Neuromuscular diseases and Covid-19: Advices from scientific societies and early observations in Italy

C. Angelini, G. Siciliano, 2020, European journal of translational myology.

Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration

C. Angelini, A. Merico, V. Pegoraro, 2017, Journal of the Neurological Sciences.

A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

L. Santoro, C. Angelini, G. Siciliano, 2010, Muscle & nerve.

NIACIN DEFICIENCY

J. Utikal, S. Goerdt, M. Zeviani, 1952 .

Measurements of CP-Violating Asymmetries in the Decay B{sup 0}{yields}K{sup +}K{sup -}K{sup 0}

C Bozzi, E Robutti, L Lista, 2007, 0706.3885.

Improved measurement of CP violation in neutral B decays to ccs RID C-5223-2009 RID C-5719-2008 RID D-1055-2009

Fry, Azzolini, Sordini, 2007 .

Measurement of the Cp Asymmetry Amplitude Sin2 with B 0 Mesons

J. Beringer, B. Brau, S. Bailey, 2022 .

“Mitochondrial neuropathies”: A survey from the large cohort of the Italian Network

G. Comi, M. Zeviani, M. Mancuso, 2016, Neuromuscular Disorders.

Performance of the BABAR silicon vertex tracker

J. Nielsen, D. Kirkby, N. Roe, 2002 .

Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.

L. Santoro, M. Zatz, C. Angelini, 2012, American journal of human genetics.

TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle

E. Hoffman, C. Angelini, M. Ermani, 2012, Journal of Pathology.

Belle II Silicon Vertex Detector

T. Bergauer, M. Friedl, C. Irmler, 2017 .

Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency

C. Angelini, C. Bruno, A. Anichini, 2011, Neurological research.

The Babar Collaboration

D. Leith, S. Schaffner, J. Beringer, 2000 .

Subject Index Vol. 12, 1993

G. Danieli, J. Annegers, A. Korczyn, 1993 .

Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease.

C. Angelini, P. Tonin, M. Filosto, 2015, The Journal of clinical endocrinology and metabolism.

[An] enumeration shall be made…

B. Traynor, C. Angelini, 2015, Neurology.

Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease

G. Comi, C. Angelini, C. Bruno, 2018, Neuromuscular Disorders.

A thermodynamical analysis of the π and K meson valence structure functions

C. Angelini, R. Pazzi, 1982 .

Developmental patterns of LDH isozymes in fast and slow muscles of the rat.

C. Angelini, C. Valfré, A. Margreth, 1970, Archives of biochemistry and biophysics.

Spinal Muscular Atrophy Type 3, Kugelberg-Welander Disease

C. Angelini, 2014 .

Measurements of CP-violating Asymmetries and Branching Fractions in B Meson Decays to eta' K

D. Leith, B. Brau, A. Soha, 2003, hep-ex/0303046.

Search for $B ??? K^{(*)}??\overline??$ and invisible quarkonium decays

Alam, Sokoloff, Giorgi, 2013 .

Search for the rare decay B ! K

X. Chen, D. Leith, K. Honscheid, 2010 .

Direct CP violating asymmetry in B0→ K+π-decays - eScholarship

S. Bailey, K. Honscheid, D. Kirkby, 2004, hep-ex/0407057.